Gene Symbol | Gene ID | Gene Info |
---|---|---|
Pax3
|
ENSMUSG00000004872.9 | paired box 3 |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr1_78196894_78197345 | Pax3 | 6 | 0.982566 | 0.90 | 1.0e-20 | Click! |
chr1_78190714_78190948 | Pax3 | 6007 | 0.244548 | 0.89 | 4.7e-20 | Click! |
chr1_78189489_78189834 | Pax3 | 7177 | 0.238426 | 0.89 | 3.1e-19 | Click! |
chr1_78139520_78139674 | Pax3 | 57241 | 0.134351 | 0.86 | 6.3e-17 | Click! |
chr1_78190974_78191125 | Pax3 | 5789 | 0.246080 | 0.86 | 8.3e-17 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr12_44839950_44840386 | 31.26 |
Gm15901 |
predicted gene 15901 |
83012 |
0.1 |
chr16_73105586_73105768 | 30.38 |
4930500H12Rik |
RIKEN cDNA 4930500H12 gene |
6689 |
0.32 |
chr2_109510678_109511034 | 27.11 |
Gm13925 |
predicted gene 13925 |
33853 |
0.19 |
chr2_101592687_101592869 | 22.86 |
B230118H07Rik |
RIKEN cDNA B230118H07 gene |
7844 |
0.19 |
chr13_36283221_36283410 | 21.99 |
Gm48766 |
predicted gene, 48766 |
30956 |
0.17 |
chr16_44679478_44679930 | 21.75 |
Nepro |
nucleolus and neural progenitor protein |
44597 |
0.13 |
chr3_35088716_35089116 | 21.66 |
Mir6378 |
microRNA 6378 |
166265 |
0.03 |
chr7_49699122_49699310 | 20.81 |
Htatip2 |
HIV-1 Tat interactive protein 2 |
59899 |
0.11 |
chr17_93312268_93312434 | 20.35 |
Gm9665 |
predicted gene 9665 |
4910 |
0.23 |
chr10_22609004_22609241 | 19.51 |
Slc2a12 |
solute carrier family 2 (facilitated glucose transporter), member 12 |
35889 |
0.16 |
chr1_19951381_19951572 | 19.17 |
Gm37315 |
predicted gene, 37315 |
114072 |
0.07 |
chr10_69744304_69744513 | 19.03 |
Ank3 |
ankyrin 3, epithelial |
37930 |
0.22 |
chr2_135101472_135101629 | 18.91 |
4930545L23Rik |
RIKEN cDNA 4930545L23 gene |
114066 |
0.07 |
chr4_54652781_54653068 | 18.65 |
Gm12480 |
predicted gene 12480 |
1021 |
0.48 |
chr6_23281324_23281501 | 18.55 |
C130093G08Rik |
RIKEN cDNA C130093G08 gene |
30279 |
0.15 |
chr1_57875514_57875995 | 18.51 |
Spats2l |
spermatogenesis associated, serine-rich 2-like |
26317 |
0.18 |
chrX_133575644_133575926 | 18.40 |
Pcdh19 |
protocadherin 19 |
12226 |
0.29 |
chr8_14381805_14382050 | 18.28 |
Dlgap2 |
DLG associated protein 2 |
21 |
0.98 |
chr4_28300161_28300466 | 18.16 |
Gm11907 |
predicted gene 11907 |
53470 |
0.15 |
chr5_26991582_26992107 | 17.81 |
Gm16057 |
predicted gene 16057 |
15777 |
0.25 |
chr9_45651665_45651844 | 17.64 |
Gm22069 |
predicted gene, 22069 |
16942 |
0.18 |
chr2_151967516_151967853 | 17.55 |
Mir1953 |
microRNA 1953 |
67 |
0.96 |
chr13_84448589_84449243 | 17.26 |
Gm26927 |
predicted gene, 26927 |
108803 |
0.07 |
chr16_64524149_64524300 | 17.06 |
Csnka2ip |
casein kinase 2, alpha prime interacting protein |
45076 |
0.2 |
chr7_118992569_118993054 | 17.04 |
Gprc5b |
G protein-coupled receptor, family C, group 5, member B |
2400 |
0.3 |
chrX_105391659_105392013 | 16.98 |
5330434G04Rik |
RIKEN cDNA 5330434G04 gene |
60 |
0.97 |
chr18_50397132_50397306 | 16.96 |
Fam170a |
family with sequence similarity 170, member A |
118848 |
0.06 |
chr1_155759163_155759336 | 16.75 |
Gm37089 |
predicted gene, 37089 |
6897 |
0.14 |
chr4_15550682_15550851 | 16.75 |
Gm11859 |
predicted gene 11859 |
18655 |
0.22 |
chr11_36121226_36121389 | 16.66 |
Gm12126 |
predicted gene 12126 |
40643 |
0.19 |
chr2_64394982_64395325 | 16.63 |
Gm13575 |
predicted gene 13575 |
1293 |
0.6 |
chr9_22035312_22035600 | 16.55 |
Elavl3 |
ELAV like RNA binding protein 3 |
9082 |
0.08 |
chr1_38263371_38263535 | 16.42 |
Gm16150 |
predicted gene 16150 |
23753 |
0.18 |
chr3_40686919_40687079 | 16.28 |
Intu |
inturned planar cell polarity protein |
14378 |
0.15 |
chr13_83868187_83868361 | 16.15 |
2810049E08Rik |
RIKEN cDNA 2810049E08 gene |
22934 |
0.17 |
chr10_13107920_13108404 | 16.13 |
Plagl1 |
pleiomorphic adenoma gene-like 1 |
5303 |
0.23 |
chr3_122805376_122805564 | 16.01 |
4930447N08Rik |
RIKEN cDNA 4930447N08 gene |
3422 |
0.18 |
chr15_12094258_12094425 | 15.97 |
Gm34759 |
predicted gene, 34759 |
9144 |
0.16 |
chr2_146262046_146262668 | 15.58 |
Ralgapa2 |
Ral GTPase activating protein, alpha subunit 2 (catalytic) |
982 |
0.51 |
chr7_73917720_73918558 | 15.33 |
Gm45003 |
predicted gene 45003 |
29395 |
0.14 |
chr18_14305121_14305422 | 15.27 |
Gm50095 |
predicted gene, 50095 |
3116 |
0.25 |
chr9_23378360_23378672 | 15.25 |
Bmper |
BMP-binding endothelial regulator |
4584 |
0.36 |
chr3_102353639_102353854 | 15.07 |
Gm43242 |
predicted gene 43242 |
15416 |
0.18 |
chr4_20261214_20261407 | 15.04 |
Gm11872 |
predicted gene 11872 |
82396 |
0.1 |
chr4_52211117_52211359 | 15.02 |
Gm12466 |
predicted gene 12466 |
29665 |
0.18 |
chr16_3238621_3239720 | 14.97 |
Gm23215 |
predicted gene, 23215 |
10414 |
0.18 |
chr13_114642103_114642263 | 14.95 |
4930544M13Rik |
RIKEN cDNA 4930544M13 gene |
34946 |
0.16 |
chr2_17669903_17670152 | 14.73 |
Nebl |
nebulette |
61016 |
0.13 |
chr11_71758404_71758886 | 14.64 |
Wscd1 |
WSC domain containing 1 |
7269 |
0.18 |
chr4_32359158_32359334 | 14.53 |
Bach2 |
BTB and CNC homology, basic leucine zipper transcription factor 2 |
58189 |
0.13 |
chr3_35089121_35089279 | 14.52 |
Mir6378 |
microRNA 6378 |
166549 |
0.03 |
chr3_8509423_8509607 | 14.41 |
Stmn2 |
stathmin-like 2 |
0 |
0.98 |
chr17_9763182_9763333 | 14.31 |
4930452A19Rik |
RIKEN cDNA 4930452A19 gene |
12609 |
0.21 |
chr8_90741015_90741332 | 14.28 |
Gm35850 |
predicted gene, 35850 |
398 |
0.82 |
chr18_56621180_56621368 | 14.09 |
Gm50288 |
predicted gene, 50288 |
177 |
0.93 |
chr7_34939277_34939526 | 14.00 |
Gm25922 |
predicted gene, 25922 |
4584 |
0.19 |
chr19_41164447_41164691 | 13.98 |
Tll2 |
tolloid-like 2 |
42205 |
0.16 |
chr5_66492260_66492411 | 13.97 |
Apbb2 |
amyloid beta (A4) precursor protein-binding, family B, member 2 |
163 |
0.94 |
chr12_41487074_41487242 | 13.91 |
Lrrn3 |
leucine rich repeat protein 3, neuronal |
727 |
0.73 |
chr6_108145994_108146240 | 13.90 |
Sumf1 |
sulfatase modifying factor 1 |
1422 |
0.44 |
chr5_52294533_52294689 | 13.83 |
Gm43179 |
predicted gene 43179 |
47749 |
0.09 |
chrX_161480448_161480798 | 13.78 |
Prkaca-ps1 |
protein kinase, cAMP dependent, catalytic, alpha pseudogene 1 |
5862 |
0.33 |
chr1_129208294_129208780 | 13.78 |
Thsd7b |
thrombospondin, type I, domain containing 7B |
64765 |
0.13 |
chr1_125996798_125996949 | 13.64 |
Nckap5 |
NCK-associated protein 5 |
26230 |
0.21 |
chr1_40547427_40547578 | 13.59 |
Il18rap |
interleukin 18 receptor accessory protein |
5810 |
0.18 |
chr4_130814793_130815005 | 13.57 |
Sdc3 |
syndecan 3 |
595 |
0.6 |
chr17_75020138_75020289 | 13.51 |
Ltbp1 |
latent transforming growth factor beta binding protein 1 |
13919 |
0.23 |
chr5_28209816_28210203 | 13.49 |
Cnpy1 |
canopy FGF signaling regulator 1 |
13 |
0.98 |
chr6_6163350_6163566 | 13.36 |
Slc25a13 |
solute carrier family 25 (mitochondrial carrier, adenine nucleotide translocator), member 13 |
10493 |
0.26 |
chr4_40014905_40015074 | 13.32 |
Gm26087 |
predicted gene, 26087 |
33431 |
0.16 |
chr14_76255061_76255467 | 13.32 |
2900040C04Rik |
RIKEN cDNA 2900040C04 gene |
3807 |
0.27 |
chr3_10776382_10776609 | 13.18 |
Gm37244 |
predicted gene, 37244 |
1596 |
0.45 |
chr13_103795019_103795175 | 13.09 |
Srek1 |
splicing regulatory glutamine/lysine-rich protein 1 |
20489 |
0.23 |
chr1_68178622_68178922 | 13.00 |
Gm37100 |
predicted gene, 37100 |
62225 |
0.13 |
chr18_13591496_13591936 | 12.99 |
AC103362.1 |
novel transcript |
9684 |
0.31 |
chr13_9355426_9355612 | 12.96 |
Gm48869 |
predicted gene, 48869 |
3491 |
0.17 |
chr4_66215443_66215596 | 12.89 |
Gm11484 |
predicted gene 11484 |
138330 |
0.05 |
chr4_75561854_75562168 | 12.86 |
Gm11259 |
predicted gene 11259 |
181251 |
0.03 |
chr14_75540763_75541352 | 12.81 |
Cby2 |
chibby family member 2 |
50892 |
0.13 |
chr7_30785794_30786000 | 12.72 |
Krtdap |
keratinocyte differentiation associated protein |
1999 |
0.15 |
chr17_90087882_90088033 | 12.67 |
Nrxn1 |
neurexin I |
183 |
0.97 |
chr1_46830172_46830391 | 12.58 |
Slc39a10 |
solute carrier family 39 (zinc transporter), member 10 |
5618 |
0.22 |
chr2_136387430_136388483 | 12.56 |
Pak7 |
p21 (RAC1) activated kinase 7 |
4 |
0.98 |
chr12_117265315_117265466 | 12.53 |
Mir153 |
microRNA 153 |
14573 |
0.26 |
chr10_53429915_53430130 | 12.53 |
Gm36229 |
predicted gene, 36229 |
20140 |
0.13 |
chr13_83722095_83722570 | 12.51 |
C130071C03Rik |
RIKEN cDNA C130071C03 gene |
951 |
0.46 |
chr11_44900591_44900793 | 12.47 |
Ebf1 |
early B cell factor 1 |
11446 |
0.29 |
chr1_73758468_73758663 | 12.39 |
Gm25329 |
predicted gene, 25329 |
5145 |
0.23 |
chr7_92235525_92235967 | 12.38 |
Dlg2 |
discs large MAGUK scaffold protein 2 |
619 |
0.81 |
chr6_17143183_17143334 | 12.35 |
Gm4876 |
predicted gene 4876 |
28207 |
0.18 |
chrX_66470042_66470193 | 12.24 |
4930447F04Rik |
RIKEN cDNA 4930447F04 gene |
165893 |
0.03 |
chr16_63092023_63092220 | 12.22 |
Gm49621 |
predicted gene, 49621 |
19569 |
0.25 |
chr2_16450899_16451272 | 12.17 |
Plxdc2 |
plexin domain containing 2 |
93968 |
0.1 |
chr2_38348352_38348831 | 12.13 |
Gm27197 |
predicted gene 27197 |
275 |
0.87 |
chr19_22448468_22448703 | 12.12 |
Gm27151 |
predicted gene 27151 |
280 |
0.57 |
chr18_79067870_79068021 | 12.10 |
Setbp1 |
SET binding protein 1 |
41446 |
0.2 |
chr4_62275236_62275526 | 12.06 |
Gm23148 |
predicted gene, 23148 |
11067 |
0.15 |
chr15_12039646_12039856 | 12.03 |
Gm2559 |
predicted gene 2559 |
7824 |
0.18 |
chr19_29844410_29844642 | 12.02 |
Gm50380 |
predicted gene, 50380 |
30691 |
0.13 |
chr8_35883513_35883804 | 12.01 |
5430403N17Rik |
RIKEN cDNA 5430403N17 gene |
701 |
0.71 |
chr2_46666527_46666896 | 11.95 |
Gm25264 |
predicted gene, 25264 |
59628 |
0.16 |
chr9_40346401_40346595 | 11.89 |
Gramd1b |
GRAM domain containing 1B |
208 |
0.89 |
chr10_87059004_87059195 | 11.86 |
1700113H08Rik |
RIKEN cDNA 1700113H08 gene |
1053 |
0.55 |
chr3_95972775_95973269 | 11.82 |
Gm20940 |
predicted gene, 20940 |
8634 |
0.1 |
chr13_34136680_34136848 | 11.78 |
Gm36500 |
predicted gene, 36500 |
2904 |
0.15 |
chr13_45469662_45470092 | 11.72 |
Gm23387 |
predicted gene, 23387 |
16453 |
0.19 |
chr11_112826638_112826789 | 11.64 |
4933434M16Rik |
RIKEN cDNA 4933434M16 gene |
1534 |
0.42 |
chr14_11960906_11961113 | 11.61 |
Gm3848 |
predicted gene 3848 |
20199 |
0.22 |
chr7_37689113_37689410 | 11.55 |
4930505M18Rik |
RIKEN cDNA 4930505M18 gene |
19462 |
0.2 |
chr1_12811190_12811461 | 11.55 |
Sulf1 |
sulfatase 1 |
24703 |
0.22 |
chr14_11823146_11823308 | 11.54 |
Gm48601 |
predicted gene, 48601 |
44367 |
0.15 |
chr5_103938647_103939049 | 11.51 |
Klhl8 |
kelch-like 8 |
27589 |
0.12 |
chr19_21780101_21780484 | 11.51 |
Cemip2 |
cell migration inducing hyaluronidase 2 |
1904 |
0.37 |
chr4_24544564_24544876 | 11.47 |
Mms22l |
MMS22-like, DNA repair protein |
8372 |
0.28 |
chr2_159002966_159003144 | 11.39 |
Gm44319 |
predicted gene, 44319 |
66808 |
0.12 |
chr2_50755626_50755796 | 11.36 |
Gm13484 |
predicted gene 13484 |
97644 |
0.08 |
chr2_102097729_102097880 | 11.18 |
Gm13920 |
predicted gene 13920 |
40217 |
0.14 |
chr6_55579639_55579954 | 11.15 |
Gm44352 |
predicted gene, 44352 |
46290 |
0.15 |
chr11_84525453_84525689 | 11.14 |
Lhx1 |
LIM homeobox protein 1 |
36 |
0.55 |
chr7_120034706_120034857 | 11.11 |
Dnah3 |
dynein, axonemal, heavy chain 3 |
55899 |
0.09 |
chr8_57962515_57962681 | 11.02 |
Galntl6 |
UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase-like 6 |
34 |
0.99 |
chr16_17987771_17988057 | 10.96 |
Vpreb2 |
pre-B lymphocyte gene 2 |
7486 |
0.13 |
chr1_48276328_48276479 | 10.96 |
Gm5974 |
predicted gene 5974 |
38448 |
0.22 |
chr16_91246366_91246564 | 10.96 |
Gm37016 |
predicted gene, 37016 |
16033 |
0.11 |
chr12_50187080_50187231 | 10.95 |
Gm40418 |
predicted gene, 40418 |
66846 |
0.15 |
chr6_101550899_101551107 | 10.94 |
Gm44171 |
predicted gene, 44171 |
12250 |
0.22 |
chr9_73725809_73725962 | 10.93 |
Gm27148 |
predicted gene 27148 |
49193 |
0.15 |
chr18_29263094_29263266 | 10.92 |
Gm34743 |
predicted gene, 34743 |
17833 |
0.29 |
chr19_24812857_24813008 | 10.91 |
Gm50342 |
predicted gene, 50342 |
43264 |
0.12 |
chr1_14108426_14108817 | 10.88 |
Gm37400 |
predicted gene, 37400 |
4198 |
0.31 |
chr4_125534653_125535467 | 10.86 |
Mir692-2 |
microRNA 692-2 |
30311 |
0.17 |
chr13_54987439_54987692 | 10.85 |
Unc5a |
unc-5 netrin receptor A |
8974 |
0.16 |
chr1_164460892_164461591 | 10.81 |
Gm32391 |
predicted gene, 32391 |
1201 |
0.38 |
chr14_73632691_73632912 | 10.80 |
Gm21750 |
predicted gene, 21750 |
28424 |
0.16 |
chr5_66635546_66635697 | 10.75 |
Apbb2 |
amyloid beta (A4) precursor protein-binding, family B, member 2 |
16837 |
0.14 |
chr6_54565112_54565286 | 10.70 |
Scrn1 |
secernin 1 |
1290 |
0.42 |
chr15_7194205_7194516 | 10.63 |
Egflam |
EGF-like, fibronectin type III and laminin G domains |
28709 |
0.2 |
chr3_7943621_7943811 | 10.63 |
1700010I02Rik |
RIKEN cDNA 1700010I02 gene |
11166 |
0.27 |
chr10_46045585_46045755 | 10.58 |
Gpx4-ps2 |
glutathione peroxidase 4, pseudogene 2 |
170365 |
0.03 |
chr10_57001381_57001682 | 10.58 |
Gm36827 |
predicted gene, 36827 |
19299 |
0.24 |
chr6_127363309_127363903 | 10.51 |
Gm43631 |
predicted gene 43631 |
4873 |
0.16 |
chr9_52278756_52278921 | 10.46 |
Gm25562 |
predicted gene, 25562 |
12361 |
0.23 |
chr15_56692188_56692969 | 10.43 |
Has2os |
hyaluronan synthase 2, opposite strand |
974 |
0.55 |
chr18_23494681_23494880 | 10.38 |
Dtna |
dystrobrevin alpha |
2055 |
0.46 |
chr11_25156710_25156955 | 10.37 |
4933427E13Rik |
RIKEN cDNA 4933427E13 gene |
75794 |
0.11 |
chr3_35404611_35404796 | 10.28 |
Gm43078 |
predicted gene 43078 |
9130 |
0.26 |
chr13_81633058_81633438 | 10.28 |
Adgrv1 |
adhesion G protein-coupled receptor V1 |
94 |
0.97 |
chr14_62585498_62585685 | 10.28 |
Gm4131 |
predicted gene 4131 |
18670 |
0.12 |
chr1_175692535_175693373 | 10.25 |
Chml |
choroideremia-like |
53 |
0.67 |
chr5_85239463_85240008 | 10.23 |
Gm21006 |
predicted gene, 21006 |
372890 |
0.01 |
chr12_39956504_39956700 | 10.23 |
Gm18939 |
predicted gene, 18939 |
5970 |
0.21 |
chr1_157507333_157507489 | 10.19 |
Sec16b |
SEC16 homolog B (S. cerevisiae) |
601 |
0.68 |
chr18_44573417_44573637 | 10.10 |
Mcc |
mutated in colorectal cancers |
54011 |
0.14 |
chr17_51584267_51584452 | 10.08 |
Gm31143 |
predicted gene, 31143 |
49501 |
0.15 |
chr8_90669516_90669667 | 10.03 |
Gm45639 |
predicted gene 45639 |
5367 |
0.21 |
chr17_93203251_93203701 | 9.98 |
Adcyap1 |
adenylate cyclase activating polypeptide 1 |
1400 |
0.41 |
chrX_13207639_13208350 | 9.94 |
Rpl3-ps1 |
ribosomal protein L3, pseudogene 1 |
5423 |
0.11 |
chr18_55763810_55763961 | 9.84 |
Gm26959 |
predicted gene, 26959 |
17657 |
0.23 |
chr7_65018069_65018366 | 9.84 |
Gm25249 |
predicted gene, 25249 |
61641 |
0.12 |
chr15_44860301_44860452 | 9.81 |
A930017M01Rik |
RIKEN cDNA A930017M01 gene |
21043 |
0.2 |
chr12_61322173_61322430 | 9.79 |
Gm7745 |
predicted gene 7745 |
31590 |
0.18 |
chr15_82293240_82293859 | 9.79 |
Wbp2nl |
WBP2 N-terminal like |
5405 |
0.09 |
chr14_23723843_23723994 | 9.78 |
Kcnma1 |
potassium large conductance calcium-activated channel, subfamily M, alpha member 1 |
8206 |
0.3 |
chr2_115726894_115727056 | 9.77 |
Mir1951 |
microRNA 1951 |
88250 |
0.09 |
chr1_115784817_115785014 | 9.76 |
Cntnap5a |
contactin associated protein-like 5A |
100159 |
0.08 |
chr2_66028839_66029192 | 9.74 |
Galnt3 |
polypeptide N-acetylgalactosaminyltransferase 3 |
65056 |
0.1 |
chr7_84402158_84402326 | 9.68 |
Arnt2 |
aryl hydrocarbon receptor nuclear translocator 2 |
7641 |
0.18 |
chr3_105407968_105408119 | 9.66 |
Kcnd3os |
potassium voltage-gated channel, Shal-related family, member 3, opposite strand |
43684 |
0.15 |
chr12_49974567_49975039 | 9.65 |
Gm7481 |
predicted gene 7481 |
133052 |
0.05 |
chr4_41858507_41858658 | 9.64 |
Gm13302 |
predicted gene 13302 |
34806 |
0.09 |
chr4_42207748_42207899 | 9.64 |
Gm17167 |
predicted gene 17167 |
825 |
0.37 |
chr15_52464304_52464569 | 9.62 |
Rpl15-ps6 |
ribosomal protein L15, pseudogene 6 |
13792 |
0.17 |
chr1_156184164_156184505 | 9.61 |
Fam163a |
family with sequence similarity 163, member A |
20692 |
0.16 |
chr1_152954651_152954802 | 9.60 |
Nmnat2 |
nicotinamide nucleotide adenylyltransferase 2 |
267 |
0.89 |
chr7_62046082_62046717 | 9.60 |
Mir344f |
microRNA Mir344f |
151 |
0.94 |
chr19_14301685_14301844 | 9.60 |
Gm26993 |
predicted gene, 26993 |
283393 |
0.01 |
chr13_84905713_84906063 | 9.59 |
Gm4059 |
predicted gene 4059 |
68429 |
0.12 |
chr19_41698918_41699071 | 9.59 |
Slit1 |
slit guidance ligand 1 |
44492 |
0.14 |
chr16_51590171_51590339 | 9.59 |
Gm49608 |
predicted gene, 49608 |
173307 |
0.03 |
chr7_115415334_115415502 | 9.56 |
Sox6 |
SRY (sex determining region Y)-box 6 |
182478 |
0.03 |
chr5_111660439_111660853 | 9.54 |
Gm42489 |
predicted gene 42489 |
67030 |
0.09 |
chr12_13056390_13056541 | 9.53 |
Gm48209 |
predicted gene, 48209 |
1736 |
0.34 |
chr7_144285335_144285486 | 9.51 |
Shank2 |
SH3 and multiple ankyrin repeat domains 2 |
865 |
0.7 |
chr16_42781243_42781583 | 9.49 |
4932412D23Rik |
RIKEN cDNA 4932412D23 gene |
94174 |
0.08 |
chr5_48544893_48545047 | 9.49 |
Gm43831 |
predicted gene 43831 |
7029 |
0.2 |
chr8_7946619_7946770 | 9.47 |
Gm45160 |
predicted gene 45160 |
38674 |
0.19 |
chr12_33061725_33061987 | 9.44 |
Cdhr3 |
cadherin-related family member 3 |
64 |
0.9 |
chr5_42776882_42777080 | 9.41 |
Gm5554 |
predicted gene 5554 |
187628 |
0.03 |
chr3_122805097_122805255 | 9.36 |
4930447N08Rik |
RIKEN cDNA 4930447N08 gene |
3128 |
0.19 |
chr14_69057480_69057771 | 9.35 |
Gm41192 |
predicted gene, 41192 |
27973 |
0.15 |
chr4_146483728_146484147 | 9.34 |
Gm13245 |
predicted gene 13245 |
3270 |
0.18 |
chr2_56662417_56662586 | 9.32 |
Mir195b |
microRNA 195b |
123310 |
0.06 |
chr4_82532408_82532766 | 9.29 |
Gm11266 |
predicted gene 11266 |
24571 |
0.17 |
chr9_71879542_71879779 | 9.29 |
Tcf12 |
transcription factor 12 |
5051 |
0.13 |
chr3_39610074_39610225 | 9.28 |
Gm42781 |
predicted gene 42781 |
25910 |
0.19 |
chr12_72374272_72374473 | 9.28 |
Rtn1 |
reticulon 1 |
34682 |
0.18 |
chr2_143807122_143807273 | 9.23 |
Pcsk2os2 |
proprotein convertase subtilisin/kexin type 2, opposite strand 2 |
11232 |
0.19 |
chr7_16172223_16172580 | 9.18 |
Meis3 |
Meis homeobox 3 |
2689 |
0.17 |
chr16_67061894_67062045 | 9.18 |
Cadm2 |
cell adhesion molecule 2 |
108635 |
0.07 |
chr2_31500907_31501058 | 9.16 |
Ass1 |
argininosuccinate synthetase 1 |
256 |
0.92 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
4.4 | 13.3 | GO:0097118 | neuroligin clustering involved in postsynaptic membrane assembly(GO:0097118) |
3.5 | 14.1 | GO:0031117 | positive regulation of microtubule depolymerization(GO:0031117) |
3.1 | 9.4 | GO:0019355 | nicotinamide nucleotide biosynthetic process from aspartate(GO:0019355) 'de novo' NAD biosynthetic process from aspartate(GO:0034628) |
2.8 | 8.5 | GO:0045163 | clustering of voltage-gated potassium channels(GO:0045163) |
2.8 | 8.4 | GO:0060178 | regulation of exocyst localization(GO:0060178) |
2.5 | 7.4 | GO:0010046 | response to mycotoxin(GO:0010046) |
2.3 | 7.0 | GO:2000698 | positive regulation of epithelial cell differentiation involved in kidney development(GO:2000698) |
2.2 | 11.2 | GO:0010739 | positive regulation of protein kinase A signaling(GO:0010739) |
2.1 | 6.3 | GO:0003221 | right ventricular cardiac muscle tissue morphogenesis(GO:0003221) |
2.1 | 6.2 | GO:0048208 | vesicle targeting, rough ER to cis-Golgi(GO:0048207) COPII vesicle coating(GO:0048208) |
1.9 | 5.8 | GO:0002877 | regulation of acute inflammatory response to non-antigenic stimulus(GO:0002877) |
1.8 | 12.3 | GO:0045161 | neuronal ion channel clustering(GO:0045161) |
1.7 | 5.0 | GO:0002331 | pre-B cell allelic exclusion(GO:0002331) |
1.7 | 5.0 | GO:0060618 | nipple development(GO:0060618) |
1.6 | 4.9 | GO:0072092 | ureteric bud invasion(GO:0072092) |
1.5 | 4.5 | GO:0035860 | glial cell-derived neurotrophic factor receptor signaling pathway(GO:0035860) |
1.5 | 4.5 | GO:1900825 | regulation of membrane depolarization during cardiac muscle cell action potential(GO:1900825) |
1.4 | 4.3 | GO:0032289 | central nervous system myelin formation(GO:0032289) |
1.4 | 4.3 | GO:0055118 | negative regulation of cardiac muscle contraction(GO:0055118) |
1.4 | 4.3 | GO:0021529 | spinal cord oligodendrocyte cell differentiation(GO:0021529) spinal cord oligodendrocyte cell fate specification(GO:0021530) |
1.4 | 2.8 | GO:1901740 | negative regulation of myoblast fusion(GO:1901740) |
1.4 | 1.4 | GO:0097091 | synaptic vesicle clustering(GO:0097091) |
1.3 | 4.0 | GO:0045196 | establishment or maintenance of neuroblast polarity(GO:0045196) establishment of neuroblast polarity(GO:0045200) |
1.3 | 4.0 | GO:0043490 | malate-aspartate shuttle(GO:0043490) |
1.3 | 9.0 | GO:0042118 | endothelial cell activation(GO:0042118) |
1.3 | 3.9 | GO:1901252 | regulation of intracellular transport of viral material(GO:1901252) |
1.3 | 6.4 | GO:0098814 | spontaneous neurotransmitter secretion(GO:0061669) spontaneous synaptic transmission(GO:0098814) |
1.2 | 3.7 | GO:0018242 | protein O-linked glycosylation via serine(GO:0018242) |
1.2 | 4.9 | GO:0060221 | retinal rod cell differentiation(GO:0060221) |
1.1 | 3.4 | GO:0042231 | interleukin-13 biosynthetic process(GO:0042231) |
1.1 | 3.2 | GO:0051182 | coenzyme transport(GO:0051182) |
1.1 | 3.2 | GO:2000111 | positive regulation of macrophage apoptotic process(GO:2000111) |
1.0 | 3.1 | GO:0042126 | nitrate metabolic process(GO:0042126) |
1.0 | 3.0 | GO:0098904 | regulation of AV node cell action potential(GO:0098904) |
1.0 | 1.0 | GO:0061081 | positive regulation of myeloid leukocyte cytokine production involved in immune response(GO:0061081) |
1.0 | 4.8 | GO:0021960 | anterior commissure morphogenesis(GO:0021960) |
0.9 | 1.9 | GO:0042322 | negative regulation of circadian sleep/wake cycle, REM sleep(GO:0042322) |
0.9 | 2.7 | GO:0070649 | formin-nucleated actin cable assembly(GO:0070649) |
0.9 | 2.7 | GO:0090274 | positive regulation of somatostatin secretion(GO:0090274) |
0.9 | 3.6 | GO:1904304 | regulation of gastro-intestinal system smooth muscle contraction(GO:1904304) |
0.9 | 2.7 | GO:0045897 | regulation of transcription during mitosis(GO:0045896) positive regulation of transcription during mitosis(GO:0045897) |
0.9 | 9.7 | GO:0071625 | vocalization behavior(GO:0071625) |
0.9 | 2.6 | GO:0021564 | vagus nerve development(GO:0021564) |
0.9 | 3.4 | GO:2001184 | positive regulation of interleukin-12 secretion(GO:2001184) |
0.9 | 2.6 | GO:0098598 | vocal learning(GO:0042297) imitative learning(GO:0098596) learned vocalization behavior or vocal learning(GO:0098598) |
0.8 | 5.1 | GO:0060907 | positive regulation of macrophage cytokine production(GO:0060907) |
0.8 | 2.5 | GO:0036444 | calcium ion transmembrane import into mitochondrion(GO:0036444) |
0.8 | 2.5 | GO:0021557 | oculomotor nerve development(GO:0021557) |
0.8 | 6.4 | GO:0018344 | protein geranylgeranylation(GO:0018344) |
0.8 | 0.8 | GO:0051610 | negative regulation of neurotransmitter uptake(GO:0051581) serotonin uptake(GO:0051610) regulation of serotonin uptake(GO:0051611) negative regulation of serotonin uptake(GO:0051612) |
0.8 | 6.3 | GO:0071404 | cellular response to low-density lipoprotein particle stimulus(GO:0071404) |
0.8 | 3.1 | GO:1900454 | positive regulation of long term synaptic depression(GO:1900454) |
0.8 | 3.9 | GO:0016576 | histone dephosphorylation(GO:0016576) |
0.8 | 3.8 | GO:0060373 | regulation of ventricular cardiac muscle cell membrane depolarization(GO:0060373) |
0.8 | 3.1 | GO:0002924 | negative regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002924) |
0.8 | 2.3 | GO:0021823 | cerebral cortex tangential migration using cell-cell interactions(GO:0021823) postnatal olfactory bulb interneuron migration(GO:0021827) |
0.8 | 9.1 | GO:0003356 | regulation of cilium beat frequency(GO:0003356) |
0.7 | 1.5 | GO:0008038 | neuron recognition(GO:0008038) |
0.7 | 2.2 | GO:0006420 | arginyl-tRNA aminoacylation(GO:0006420) |
0.7 | 2.9 | GO:0006432 | phenylalanyl-tRNA aminoacylation(GO:0006432) |
0.7 | 5.0 | GO:0035881 | amacrine cell differentiation(GO:0035881) |
0.7 | 2.7 | GO:0018211 | protein C-linked glycosylation(GO:0018103) peptidyl-tryptophan modification(GO:0018211) protein C-linked glycosylation via tryptophan(GO:0018317) protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan(GO:0018406) |
0.7 | 2.7 | GO:0036135 | Schwann cell migration(GO:0036135) regulation of Schwann cell migration(GO:1900147) |
0.7 | 2.6 | GO:0038165 | oncostatin-M-mediated signaling pathway(GO:0038165) |
0.7 | 3.3 | GO:0003357 | noradrenergic neuron differentiation(GO:0003357) |
0.6 | 4.5 | GO:0046069 | cGMP catabolic process(GO:0046069) |
0.6 | 1.3 | GO:1900623 | regulation of monocyte aggregation(GO:1900623) positive regulation of monocyte aggregation(GO:1900625) |
0.6 | 1.9 | GO:0035434 | copper ion transmembrane transport(GO:0035434) |
0.6 | 3.7 | GO:0021957 | corticospinal tract morphogenesis(GO:0021957) |
0.6 | 1.8 | GO:1904017 | response to Thyroglobulin triiodothyronine(GO:1904016) cellular response to Thyroglobulin triiodothyronine(GO:1904017) |
0.6 | 3.7 | GO:0019262 | N-acetylneuraminate catabolic process(GO:0019262) |
0.6 | 1.8 | GO:0007525 | somatic muscle development(GO:0007525) |
0.6 | 2.9 | GO:0021797 | forebrain anterior/posterior pattern specification(GO:0021797) |
0.6 | 0.6 | GO:0060164 | regulation of timing of neuron differentiation(GO:0060164) |
0.6 | 2.9 | GO:0021523 | somatic motor neuron differentiation(GO:0021523) |
0.6 | 2.3 | GO:1904936 | cerebral cortex GABAergic interneuron migration(GO:0021853) interneuron migration(GO:1904936) |
0.6 | 1.7 | GO:0001927 | exocyst assembly(GO:0001927) |
0.6 | 0.6 | GO:0021800 | cerebral cortex tangential migration(GO:0021800) |
0.6 | 1.1 | GO:2000384 | regulation of ectoderm development(GO:2000383) negative regulation of ectoderm development(GO:2000384) |
0.5 | 2.7 | GO:0044027 | hypermethylation of CpG island(GO:0044027) |
0.5 | 2.1 | GO:0035247 | peptidyl-arginine methylation, to asymmetrical-dimethyl arginine(GO:0019919) peptidyl-arginine omega-N-methylation(GO:0035247) |
0.5 | 3.2 | GO:0032808 | lacrimal gland development(GO:0032808) |
0.5 | 1.0 | GO:0033563 | dorsal/ventral axon guidance(GO:0033563) |
0.5 | 1.6 | GO:0072137 | condensed mesenchymal cell proliferation(GO:0072137) |
0.5 | 2.6 | GO:1903071 | positive regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903071) |
0.5 | 3.6 | GO:0090557 | establishment of endothelial intestinal barrier(GO:0090557) |
0.5 | 1.5 | GO:2000667 | positive regulation of interleukin-5 secretion(GO:2000664) positive regulation of interleukin-13 secretion(GO:2000667) |
0.5 | 1.5 | GO:1904502 | regulation of lipophagy(GO:1904502) positive regulation of lipophagy(GO:1904504) |
0.5 | 4.0 | GO:0070571 | negative regulation of neuron projection regeneration(GO:0070571) |
0.5 | 2.5 | GO:0035331 | negative regulation of hippo signaling(GO:0035331) |
0.5 | 9.2 | GO:0098926 | acetylcholine receptor signaling pathway(GO:0095500) postsynaptic signal transduction(GO:0098926) signal transduction involved in cellular response to ammonium ion(GO:1903831) response to acetylcholine(GO:1905144) cellular response to acetylcholine(GO:1905145) |
0.5 | 1.9 | GO:2001206 | positive regulation of osteoclast development(GO:2001206) |
0.5 | 0.5 | GO:0071205 | protein localization to juxtaparanode region of axon(GO:0071205) |
0.5 | 1.4 | GO:0046075 | dTTP biosynthetic process(GO:0006235) pyrimidine deoxyribonucleoside triphosphate biosynthetic process(GO:0009212) dTTP metabolic process(GO:0046075) |
0.5 | 1.4 | GO:0001827 | inner cell mass cell fate commitment(GO:0001827) |
0.5 | 2.4 | GO:0031293 | membrane protein intracellular domain proteolysis(GO:0031293) |
0.5 | 1.4 | GO:0045218 | zonula adherens maintenance(GO:0045218) |
0.5 | 1.9 | GO:0030910 | olfactory placode formation(GO:0030910) olfactory placode development(GO:0071698) olfactory placode morphogenesis(GO:0071699) |
0.5 | 1.8 | GO:0000957 | mitochondrial RNA catabolic process(GO:0000957) regulation of mitochondrial RNA catabolic process(GO:0000960) |
0.5 | 2.3 | GO:0018230 | peptidyl-L-cysteine S-palmitoylation(GO:0018230) peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine(GO:0018231) |
0.5 | 3.6 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
0.5 | 1.8 | GO:0007412 | axon target recognition(GO:0007412) |
0.4 | 1.3 | GO:0042851 | L-alanine metabolic process(GO:0042851) |
0.4 | 0.4 | GO:0021779 | oligodendrocyte cell fate specification(GO:0021778) oligodendrocyte cell fate commitment(GO:0021779) glial cell fate specification(GO:0021780) |
0.4 | 3.1 | GO:0050861 | positive regulation of B cell receptor signaling pathway(GO:0050861) |
0.4 | 6.8 | GO:0021516 | dorsal spinal cord development(GO:0021516) |
0.4 | 2.9 | GO:0021796 | cerebral cortex regionalization(GO:0021796) |
0.4 | 1.7 | GO:0090666 | scaRNA localization to Cajal body(GO:0090666) |
0.4 | 0.8 | GO:0097477 | lateral motor column neuron migration(GO:0097477) |
0.4 | 1.2 | GO:0090245 | axis elongation involved in somitogenesis(GO:0090245) |
0.4 | 0.4 | GO:0021586 | pons maturation(GO:0021586) |
0.4 | 2.0 | GO:0033564 | anterior/posterior axon guidance(GO:0033564) |
0.4 | 2.8 | GO:0019673 | GDP-mannose metabolic process(GO:0019673) |
0.4 | 5.6 | GO:0010172 | embryonic body morphogenesis(GO:0010172) |
0.4 | 2.0 | GO:0070934 | CRD-mediated mRNA stabilization(GO:0070934) |
0.4 | 1.2 | GO:0006553 | lysine metabolic process(GO:0006553) |
0.4 | 34.1 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
0.4 | 0.4 | GO:1903273 | regulation of sodium ion export(GO:1903273) positive regulation of sodium ion export(GO:1903275) regulation of sodium ion export from cell(GO:1903276) positive regulation of sodium ion export from cell(GO:1903278) |
0.4 | 2.8 | GO:0044387 | negative regulation of protein kinase activity by regulation of protein phosphorylation(GO:0044387) |
0.4 | 3.9 | GO:0060573 | ventral spinal cord interneuron specification(GO:0021521) cell fate specification involved in pattern specification(GO:0060573) |
0.4 | 0.8 | GO:1902866 | regulation of retina development in camera-type eye(GO:1902866) |
0.4 | 1.1 | GO:1903999 | negative regulation of eating behavior(GO:1903999) |
0.4 | 1.9 | GO:0045113 | regulation of integrin biosynthetic process(GO:0045113) |
0.4 | 0.4 | GO:0060666 | dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
0.4 | 0.7 | GO:0071351 | cellular response to interleukin-18(GO:0071351) |
0.4 | 1.1 | GO:0018364 | peptidyl-glutamine methylation(GO:0018364) |
0.4 | 1.1 | GO:0016199 | axon midline choice point recognition(GO:0016199) |
0.4 | 1.1 | GO:0006842 | tricarboxylic acid transport(GO:0006842) citrate transport(GO:0015746) |
0.4 | 1.1 | GO:1901843 | positive regulation of high voltage-gated calcium channel activity(GO:1901843) |
0.4 | 0.7 | GO:0055005 | ventricular cardiac myofibril assembly(GO:0055005) |
0.4 | 0.7 | GO:1903261 | regulation of serine phosphorylation of STAT3 protein(GO:1903261) |
0.4 | 0.7 | GO:0070340 | detection of bacterial lipopeptide(GO:0070340) |
0.4 | 0.7 | GO:0021891 | olfactory bulb interneuron development(GO:0021891) |
0.4 | 1.4 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
0.4 | 0.7 | GO:0035262 | gonad morphogenesis(GO:0035262) |
0.3 | 1.0 | GO:1904217 | regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904217) positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904219) regulation of serine C-palmitoyltransferase activity(GO:1904220) positive regulation of serine C-palmitoyltransferase activity(GO:1904222) |
0.3 | 0.3 | GO:0034627 | 'de novo' NAD biosynthetic process(GO:0034627) |
0.3 | 0.7 | GO:0001998 | angiotensin mediated vasoconstriction involved in regulation of systemic arterial blood pressure(GO:0001998) |
0.3 | 2.7 | GO:0021952 | central nervous system projection neuron axonogenesis(GO:0021952) |
0.3 | 2.0 | GO:0034643 | establishment of mitochondrion localization, microtubule-mediated(GO:0034643) mitochondrion transport along microtubule(GO:0047497) |
0.3 | 1.7 | GO:0071435 | potassium ion export(GO:0071435) |
0.3 | 0.3 | GO:0003213 | cardiac right atrium morphogenesis(GO:0003213) |
0.3 | 0.7 | GO:1904059 | regulation of locomotor rhythm(GO:1904059) |
0.3 | 1.0 | GO:0046167 | glycerol-3-phosphate biosynthetic process(GO:0046167) |
0.3 | 2.0 | GO:2000672 | negative regulation of motor neuron apoptotic process(GO:2000672) |
0.3 | 3.6 | GO:0018298 | protein-chromophore linkage(GO:0018298) |
0.3 | 2.3 | GO:0045199 | maintenance of epithelial cell apical/basal polarity(GO:0045199) |
0.3 | 2.9 | GO:0008090 | retrograde axonal transport(GO:0008090) |
0.3 | 0.6 | GO:1900452 | regulation of long term synaptic depression(GO:1900452) |
0.3 | 0.9 | GO:1903279 | regulation of calcium:sodium antiporter activity(GO:1903279) |
0.3 | 0.6 | GO:0014734 | skeletal muscle hypertrophy(GO:0014734) |
0.3 | 0.6 | GO:0042668 | auditory receptor cell fate determination(GO:0042668) |
0.3 | 0.3 | GO:0071877 | regulation of adrenergic receptor signaling pathway(GO:0071877) |
0.3 | 2.8 | GO:0035428 | hexose transmembrane transport(GO:0035428) |
0.3 | 0.9 | GO:0031118 | rRNA pseudouridine synthesis(GO:0031118) |
0.3 | 0.6 | GO:0035790 | platelet-derived growth factor receptor-alpha signaling pathway(GO:0035790) |
0.3 | 0.3 | GO:2001016 | positive regulation of skeletal muscle cell differentiation(GO:2001016) |
0.3 | 1.5 | GO:0001957 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
0.3 | 1.8 | GO:0060179 | male mating behavior(GO:0060179) |
0.3 | 0.6 | GO:0035405 | histone-threonine phosphorylation(GO:0035405) |
0.3 | 16.0 | GO:0051965 | positive regulation of synapse assembly(GO:0051965) |
0.3 | 0.3 | GO:0061642 | chemoattraction of axon(GO:0061642) |
0.3 | 3.2 | GO:0090195 | chemokine secretion(GO:0090195) regulation of chemokine secretion(GO:0090196) |
0.3 | 0.9 | GO:0090296 | regulation of mitochondrial DNA replication(GO:0090296) |
0.3 | 1.8 | GO:1902222 | L-phenylalanine catabolic process(GO:0006559) erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process(GO:1902222) |
0.3 | 1.2 | GO:0009957 | epidermal cell fate specification(GO:0009957) |
0.3 | 2.9 | GO:0043586 | tongue development(GO:0043586) |
0.3 | 0.6 | GO:0061368 | behavioral response to chemical pain(GO:0061366) behavioral response to formalin induced pain(GO:0061368) |
0.3 | 1.4 | GO:0045410 | positive regulation of interleukin-6 biosynthetic process(GO:0045410) |
0.3 | 0.6 | GO:0021943 | formation of radial glial scaffolds(GO:0021943) |
0.3 | 2.0 | GO:0018158 | protein oxidation(GO:0018158) |
0.3 | 0.3 | GO:0060435 | bronchiole development(GO:0060435) |
0.3 | 0.8 | GO:0071042 | U1 snRNA 3'-end processing(GO:0034473) U5 snRNA 3'-end processing(GO:0034476) nuclear polyadenylation-dependent mRNA catabolic process(GO:0071042) polyadenylation-dependent mRNA catabolic process(GO:0071047) |
0.3 | 5.0 | GO:0048266 | behavioral response to pain(GO:0048266) |
0.3 | 0.8 | GO:0043313 | regulation of neutrophil degranulation(GO:0043313) |
0.3 | 1.4 | GO:0060480 | lung goblet cell differentiation(GO:0060480) |
0.3 | 0.5 | GO:0032025 | response to cobalt ion(GO:0032025) |
0.3 | 1.6 | GO:0032960 | regulation of inositol trisphosphate biosynthetic process(GO:0032960) |
0.3 | 0.5 | GO:0060375 | regulation of mast cell differentiation(GO:0060375) |
0.3 | 1.1 | GO:0016081 | synaptic vesicle docking(GO:0016081) |
0.3 | 0.5 | GO:0007195 | adenylate cyclase-inhibiting dopamine receptor signaling pathway(GO:0007195) |
0.3 | 2.1 | GO:0021785 | branchiomotor neuron axon guidance(GO:0021785) |
0.3 | 0.8 | GO:1901301 | regulation of cargo loading into COPII-coated vesicle(GO:1901301) |
0.3 | 0.8 | GO:0097503 | sialylation(GO:0097503) |
0.3 | 0.3 | GO:0035483 | gastric emptying(GO:0035483) |
0.3 | 2.5 | GO:0060134 | prepulse inhibition(GO:0060134) |
0.3 | 1.3 | GO:0006627 | protein processing involved in protein targeting to mitochondrion(GO:0006627) |
0.2 | 0.7 | GO:0021882 | regulation of transcription from RNA polymerase II promoter involved in forebrain neuron fate commitment(GO:0021882) commitment of multipotent stem cells to neuronal lineage in forebrain(GO:0021898) |
0.2 | 0.7 | GO:0006435 | threonyl-tRNA aminoacylation(GO:0006435) |
0.2 | 3.0 | GO:0048268 | clathrin coat assembly(GO:0048268) |
0.2 | 0.7 | GO:0033387 | putrescine biosynthetic process from ornithine(GO:0033387) |
0.2 | 1.5 | GO:0001696 | gastric acid secretion(GO:0001696) |
0.2 | 1.0 | GO:0035627 | ceramide transport(GO:0035627) |
0.2 | 0.5 | GO:0046684 | response to pyrethroid(GO:0046684) |
0.2 | 1.0 | GO:0035021 | negative regulation of Rac protein signal transduction(GO:0035021) |
0.2 | 0.5 | GO:1903802 | L-glutamate(1-) import into cell(GO:1903802) L-glutamate import into cell(GO:1990123) |
0.2 | 0.5 | GO:0003344 | pericardium morphogenesis(GO:0003344) |
0.2 | 0.7 | GO:0021794 | thalamus development(GO:0021794) |
0.2 | 0.2 | GO:0072338 | creatinine metabolic process(GO:0046449) cellular lactam metabolic process(GO:0072338) |
0.2 | 5.6 | GO:1901381 | positive regulation of potassium ion transmembrane transport(GO:1901381) |
0.2 | 0.2 | GO:0061724 | lipophagy(GO:0061724) |
0.2 | 0.7 | GO:0008355 | olfactory learning(GO:0008355) |
0.2 | 3.9 | GO:0071475 | cellular hyperosmotic salinity response(GO:0071475) |
0.2 | 0.7 | GO:1904479 | negative regulation of intestinal absorption(GO:1904479) |
0.2 | 1.6 | GO:0060536 | cartilage morphogenesis(GO:0060536) |
0.2 | 0.9 | GO:0045876 | positive regulation of sister chromatid cohesion(GO:0045876) |
0.2 | 1.8 | GO:0048934 | peripheral nervous system neuron differentiation(GO:0048934) peripheral nervous system neuron development(GO:0048935) |
0.2 | 3.6 | GO:0035418 | protein localization to synapse(GO:0035418) |
0.2 | 2.4 | GO:0060576 | intestinal epithelial cell development(GO:0060576) |
0.2 | 0.2 | GO:0048715 | negative regulation of oligodendrocyte differentiation(GO:0048715) |
0.2 | 0.7 | GO:0060672 | epithelial cell differentiation involved in embryonic placenta development(GO:0060671) epithelial cell morphogenesis involved in placental branching(GO:0060672) |
0.2 | 0.7 | GO:0010535 | positive regulation of activation of JAK2 kinase activity(GO:0010535) |
0.2 | 2.6 | GO:0001964 | startle response(GO:0001964) |
0.2 | 0.9 | GO:0050966 | detection of mechanical stimulus involved in sensory perception of pain(GO:0050966) |
0.2 | 0.6 | GO:0010578 | regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010578) positive regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010579) |
0.2 | 3.4 | GO:0043046 | DNA methylation involved in gamete generation(GO:0043046) |
0.2 | 0.8 | GO:0010792 | DNA double-strand break processing involved in repair via single-strand annealing(GO:0010792) |
0.2 | 0.6 | GO:1900242 | regulation of synaptic vesicle endocytosis(GO:1900242) |
0.2 | 1.1 | GO:0021513 | spinal cord dorsal/ventral patterning(GO:0021513) |
0.2 | 0.2 | GO:1904058 | positive regulation of sensory perception of pain(GO:1904058) |
0.2 | 0.8 | GO:0010940 | positive regulation of necrotic cell death(GO:0010940) |
0.2 | 0.4 | GO:1900109 | regulation of histone H3-K9 dimethylation(GO:1900109) |
0.2 | 0.6 | GO:0060385 | axonogenesis involved in innervation(GO:0060385) |
0.2 | 0.8 | GO:0034975 | protein folding in endoplasmic reticulum(GO:0034975) |
0.2 | 0.6 | GO:1903215 | negative regulation of protein targeting to mitochondrion(GO:1903215) |
0.2 | 1.0 | GO:0014854 | response to inactivity(GO:0014854) response to muscle inactivity(GO:0014870) response to muscle inactivity involved in regulation of muscle adaptation(GO:0014877) response to denervation involved in regulation of muscle adaptation(GO:0014894) |
0.2 | 0.4 | GO:0035609 | C-terminal protein deglutamylation(GO:0035609) |
0.2 | 1.8 | GO:0060644 | mammary gland epithelial cell differentiation(GO:0060644) |
0.2 | 0.8 | GO:0035385 | Roundabout signaling pathway(GO:0035385) |
0.2 | 1.0 | GO:0001547 | antral ovarian follicle growth(GO:0001547) |
0.2 | 0.8 | GO:0072051 | juxtaglomerular apparatus development(GO:0072051) |
0.2 | 0.4 | GO:0021798 | forebrain dorsal/ventral pattern formation(GO:0021798) |
0.2 | 0.6 | GO:0006203 | dGTP catabolic process(GO:0006203) |
0.2 | 1.0 | GO:0060052 | neurofilament cytoskeleton organization(GO:0060052) |
0.2 | 1.7 | GO:0006105 | succinate metabolic process(GO:0006105) |
0.2 | 1.2 | GO:0007343 | egg activation(GO:0007343) |
0.2 | 0.6 | GO:2000048 | negative regulation of cell-cell adhesion mediated by cadherin(GO:2000048) |
0.2 | 0.6 | GO:0046104 | thymidine metabolic process(GO:0046104) |
0.2 | 0.4 | GO:0021593 | rhombomere morphogenesis(GO:0021593) |
0.2 | 0.4 | GO:0048752 | semicircular canal morphogenesis(GO:0048752) |
0.2 | 0.6 | GO:0050717 | positive regulation of interleukin-1 alpha secretion(GO:0050717) |
0.2 | 0.8 | GO:1900029 | positive regulation of ruffle assembly(GO:1900029) |
0.2 | 0.6 | GO:1990034 | calcium ion export from cell(GO:1990034) |
0.2 | 2.5 | GO:0045793 | positive regulation of cell size(GO:0045793) |
0.2 | 0.4 | GO:0070460 | thyroid-stimulating hormone secretion(GO:0070460) |
0.2 | 1.1 | GO:0051967 | negative regulation of synaptic transmission, glutamatergic(GO:0051967) |
0.2 | 2.1 | GO:0008045 | motor neuron axon guidance(GO:0008045) |
0.2 | 0.4 | GO:0010040 | response to iron(II) ion(GO:0010040) |
0.2 | 0.2 | GO:0010901 | regulation of very-low-density lipoprotein particle remodeling(GO:0010901) |
0.2 | 0.6 | GO:0035582 | sequestering of BMP in extracellular matrix(GO:0035582) |
0.2 | 0.4 | GO:0016321 | female meiosis chromosome segregation(GO:0016321) |
0.2 | 0.4 | GO:0048149 | behavioral response to ethanol(GO:0048149) |
0.2 | 0.6 | GO:0043312 | neutrophil degranulation(GO:0043312) |
0.2 | 0.7 | GO:0014028 | notochord formation(GO:0014028) |
0.2 | 0.7 | GO:0006742 | NADP catabolic process(GO:0006742) |
0.2 | 0.2 | GO:0061346 | non-canonical Wnt signaling pathway involved in heart development(GO:0061341) planar cell polarity pathway involved in heart morphogenesis(GO:0061346) |
0.2 | 1.7 | GO:0050965 | detection of temperature stimulus involved in sensory perception(GO:0050961) detection of temperature stimulus involved in sensory perception of pain(GO:0050965) |
0.2 | 0.4 | GO:0016561 | protein import into peroxisome matrix, translocation(GO:0016561) |
0.2 | 0.7 | GO:0010510 | regulation of acetyl-CoA biosynthetic process from pyruvate(GO:0010510) |
0.2 | 0.5 | GO:0014042 | positive regulation of neuron maturation(GO:0014042) |
0.2 | 1.4 | GO:0051764 | actin crosslink formation(GO:0051764) |
0.2 | 0.4 | GO:0060750 | epithelial cell proliferation involved in mammary gland duct elongation(GO:0060750) |
0.2 | 0.5 | GO:0070634 | transepithelial ammonium transport(GO:0070634) |
0.2 | 0.4 | GO:0071847 | TNFSF11-mediated signaling pathway(GO:0071847) |
0.2 | 2.9 | GO:0071242 | cellular response to ammonium ion(GO:0071242) |
0.2 | 0.4 | GO:0007403 | glial cell fate determination(GO:0007403) |
0.2 | 0.7 | GO:0061000 | negative regulation of dendritic spine development(GO:0061000) |
0.2 | 2.3 | GO:0016973 | poly(A)+ mRNA export from nucleus(GO:0016973) |
0.2 | 0.7 | GO:0051639 | actin filament network formation(GO:0051639) |
0.2 | 2.5 | GO:0042474 | middle ear morphogenesis(GO:0042474) |
0.2 | 0.5 | GO:0023041 | neuronal signal transduction(GO:0023041) |
0.2 | 0.5 | GO:0070601 | centromeric sister chromatid cohesion(GO:0070601) |
0.2 | 0.7 | GO:0032049 | cardiolipin biosynthetic process(GO:0032049) |
0.2 | 0.5 | GO:0002018 | renin-angiotensin regulation of aldosterone production(GO:0002018) |
0.2 | 0.3 | GO:0032079 | positive regulation of endodeoxyribonuclease activity(GO:0032079) |
0.2 | 1.0 | GO:0015884 | folic acid transport(GO:0015884) |
0.2 | 2.7 | GO:0060997 | dendritic spine morphogenesis(GO:0060997) |
0.2 | 0.7 | GO:0007258 | JUN phosphorylation(GO:0007258) |
0.2 | 0.2 | GO:0034136 | negative regulation of toll-like receptor 2 signaling pathway(GO:0034136) |
0.2 | 1.5 | GO:0006122 | mitochondrial electron transport, ubiquinol to cytochrome c(GO:0006122) |
0.2 | 0.7 | GO:0060335 | positive regulation of response to interferon-gamma(GO:0060332) positive regulation of interferon-gamma-mediated signaling pathway(GO:0060335) |
0.2 | 0.3 | GO:0061055 | myotome development(GO:0061055) |
0.2 | 0.7 | GO:0010825 | positive regulation of centrosome duplication(GO:0010825) |
0.2 | 0.5 | GO:1903847 | regulation of aorta morphogenesis(GO:1903847) positive regulation of aorta morphogenesis(GO:1903849) |
0.2 | 0.3 | GO:0030576 | Cajal body organization(GO:0030576) |
0.2 | 0.2 | GO:2000828 | regulation of parathyroid hormone secretion(GO:2000828) |
0.2 | 0.5 | GO:0014053 | negative regulation of gamma-aminobutyric acid secretion(GO:0014053) |
0.2 | 0.5 | GO:0036289 | peptidyl-serine autophosphorylation(GO:0036289) |
0.2 | 0.3 | GO:0010870 | positive regulation of receptor biosynthetic process(GO:0010870) |
0.2 | 3.2 | GO:0045773 | positive regulation of axon extension(GO:0045773) |
0.2 | 0.8 | GO:0098789 | pre-mRNA cleavage required for polyadenylation(GO:0098789) |
0.2 | 0.6 | GO:0033216 | ferric iron import(GO:0033216) ferric iron import into cell(GO:0097461) |
0.2 | 0.3 | GO:0090071 | negative regulation of ribosome biogenesis(GO:0090071) |
0.2 | 1.1 | GO:0007168 | receptor guanylyl cyclase signaling pathway(GO:0007168) |
0.2 | 0.3 | GO:0033762 | response to glucagon(GO:0033762) |
0.2 | 0.5 | GO:0098908 | regulation of neuronal action potential(GO:0098908) |
0.2 | 2.2 | GO:0072505 | divalent inorganic anion homeostasis(GO:0072505) |
0.2 | 0.5 | GO:0010807 | regulation of synaptic vesicle priming(GO:0010807) |
0.2 | 3.7 | GO:0000578 | embryonic axis specification(GO:0000578) |
0.2 | 0.6 | GO:0007016 | cytoskeletal anchoring at plasma membrane(GO:0007016) |
0.2 | 14.6 | GO:0097485 | neuron projection guidance(GO:0097485) |
0.2 | 0.2 | GO:0044333 | Wnt signaling pathway involved in digestive tract morphogenesis(GO:0044333) |
0.2 | 2.4 | GO:0031297 | replication fork processing(GO:0031297) |
0.1 | 3.0 | GO:0032897 | negative regulation of viral transcription(GO:0032897) |
0.1 | 0.4 | GO:0002322 | B cell proliferation involved in immune response(GO:0002322) |
0.1 | 1.8 | GO:0071168 | protein localization to chromatin(GO:0071168) |
0.1 | 0.6 | GO:0033603 | positive regulation of dopamine secretion(GO:0033603) |
0.1 | 1.0 | GO:0038063 | collagen-activated tyrosine kinase receptor signaling pathway(GO:0038063) |
0.1 | 0.9 | GO:0031119 | tRNA pseudouridine synthesis(GO:0031119) |
0.1 | 0.6 | GO:0046909 | intermembrane transport(GO:0046909) |
0.1 | 0.4 | GO:0030920 | N-terminal peptidyl-serine acetylation(GO:0017198) N-terminal peptidyl-glutamic acid acetylation(GO:0018002) peptidyl-serine acetylation(GO:0030920) |
0.1 | 0.7 | GO:0015879 | carnitine transport(GO:0015879) |
0.1 | 0.4 | GO:0086023 | adrenergic receptor signaling pathway involved in heart process(GO:0086023) |
0.1 | 0.7 | GO:0031915 | positive regulation of synaptic plasticity(GO:0031915) |
0.1 | 0.1 | GO:1902809 | regulation of skeletal muscle fiber differentiation(GO:1902809) |
0.1 | 0.1 | GO:0060161 | positive regulation of dopamine receptor signaling pathway(GO:0060161) |
0.1 | 0.6 | GO:0089711 | L-glutamate transmembrane transport(GO:0089711) |
0.1 | 0.8 | GO:0046116 | queuosine biosynthetic process(GO:0008616) queuosine metabolic process(GO:0046116) |
0.1 | 0.6 | GO:0002091 | negative regulation of receptor internalization(GO:0002091) |
0.1 | 1.7 | GO:0043248 | proteasome assembly(GO:0043248) |
0.1 | 0.3 | GO:0048239 | negative regulation of DNA recombination at telomere(GO:0048239) regulation of DNA recombination at telomere(GO:0072695) |
0.1 | 0.4 | GO:1902774 | late endosome to lysosome transport(GO:1902774) |
0.1 | 0.3 | GO:0071930 | negative regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0071930) |
0.1 | 0.4 | GO:0071763 | nuclear membrane organization(GO:0071763) |
0.1 | 0.7 | GO:0061087 | positive regulation of histone H3-K27 methylation(GO:0061087) |
0.1 | 0.3 | GO:0015860 | purine nucleoside transmembrane transport(GO:0015860) purine-containing compound transmembrane transport(GO:0072530) nucleoside transmembrane transport(GO:1901642) |
0.1 | 0.3 | GO:0070662 | mast cell proliferation(GO:0070662) regulation of mast cell proliferation(GO:0070666) positive regulation of mast cell proliferation(GO:0070668) |
0.1 | 0.4 | GO:0002913 | positive regulation of T cell anergy(GO:0002669) positive regulation of lymphocyte anergy(GO:0002913) |
0.1 | 0.3 | GO:0060054 | positive regulation of epithelial cell proliferation involved in wound healing(GO:0060054) |
0.1 | 0.1 | GO:0003331 | regulation of extracellular matrix constituent secretion(GO:0003330) positive regulation of extracellular matrix constituent secretion(GO:0003331) |
0.1 | 0.3 | GO:0009051 | pentose-phosphate shunt, oxidative branch(GO:0009051) |
0.1 | 0.3 | GO:0003180 | aortic valve development(GO:0003176) aortic valve morphogenesis(GO:0003180) |
0.1 | 0.3 | GO:0060287 | epithelial cilium movement involved in determination of left/right asymmetry(GO:0060287) |
0.1 | 0.1 | GO:1903748 | negative regulation of establishment of protein localization to mitochondrion(GO:1903748) |
0.1 | 0.3 | GO:0051387 | negative regulation of neurotrophin TRK receptor signaling pathway(GO:0051387) |
0.1 | 0.1 | GO:0044337 | canonical Wnt signaling pathway involved in positive regulation of apoptotic process(GO:0044337) |
0.1 | 0.4 | GO:1901475 | pyruvate transmembrane transport(GO:1901475) |
0.1 | 2.7 | GO:0048642 | negative regulation of skeletal muscle tissue development(GO:0048642) |
0.1 | 0.3 | GO:0031296 | B cell costimulation(GO:0031296) |
0.1 | 0.4 | GO:0032484 | Ral protein signal transduction(GO:0032484) |
0.1 | 1.0 | GO:0099500 | synaptic vesicle fusion to presynaptic active zone membrane(GO:0031629) vesicle fusion to plasma membrane(GO:0099500) |
0.1 | 0.1 | GO:0050705 | regulation of interleukin-1 alpha secretion(GO:0050705) |
0.1 | 0.4 | GO:1904970 | brush border assembly(GO:1904970) |
0.1 | 2.0 | GO:0007214 | gamma-aminobutyric acid signaling pathway(GO:0007214) |
0.1 | 0.1 | GO:0019065 | receptor-mediated endocytosis of virus by host cell(GO:0019065) endocytosis involved in viral entry into host cell(GO:0075509) |
0.1 | 0.9 | GO:0036158 | outer dynein arm assembly(GO:0036158) |
0.1 | 1.0 | GO:0021895 | cerebral cortex neuron differentiation(GO:0021895) |
0.1 | 0.5 | GO:0070365 | hepatocyte differentiation(GO:0070365) |
0.1 | 0.2 | GO:1903336 | negative regulation of vacuolar transport(GO:1903336) |
0.1 | 0.6 | GO:0046543 | development of secondary female sexual characteristics(GO:0046543) |
0.1 | 0.7 | GO:0048245 | eosinophil chemotaxis(GO:0048245) |
0.1 | 0.4 | GO:0001504 | neurotransmitter uptake(GO:0001504) |
0.1 | 0.7 | GO:0001778 | plasma membrane repair(GO:0001778) |
0.1 | 0.4 | GO:0010748 | negative regulation of plasma membrane long-chain fatty acid transport(GO:0010748) |
0.1 | 12.1 | GO:0007626 | locomotory behavior(GO:0007626) |
0.1 | 0.1 | GO:0090325 | regulation of locomotion involved in locomotory behavior(GO:0090325) |
0.1 | 0.5 | GO:0097343 | ripoptosome assembly(GO:0097343) ripoptosome assembly involved in necroptotic process(GO:1901026) |
0.1 | 0.6 | GO:0045647 | negative regulation of erythrocyte differentiation(GO:0045647) |
0.1 | 0.4 | GO:0042276 | error-prone translesion synthesis(GO:0042276) |
0.1 | 0.8 | GO:0032509 | endosome transport via multivesicular body sorting pathway(GO:0032509) |
0.1 | 0.2 | GO:0007158 | neuron cell-cell adhesion(GO:0007158) |
0.1 | 0.8 | GO:1902715 | positive regulation of interferon-gamma secretion(GO:1902715) |
0.1 | 0.6 | GO:0046784 | viral mRNA export from host cell nucleus(GO:0046784) |
0.1 | 0.3 | GO:0015959 | diadenosine polyphosphate metabolic process(GO:0015959) |
0.1 | 0.2 | GO:0021999 | neural plate anterior/posterior regionalization(GO:0021999) |
0.1 | 0.2 | GO:0006901 | vesicle coating(GO:0006901) |
0.1 | 0.1 | GO:0002752 | cell surface pattern recognition receptor signaling pathway(GO:0002752) |
0.1 | 0.6 | GO:0033578 | protein glycosylation in Golgi(GO:0033578) |
0.1 | 0.4 | GO:0000056 | ribosomal small subunit export from nucleus(GO:0000056) |
0.1 | 0.8 | GO:0071044 | histone mRNA catabolic process(GO:0071044) |
0.1 | 0.4 | GO:0016584 | nucleosome positioning(GO:0016584) |
0.1 | 0.6 | GO:1900113 | negative regulation of histone H3-K9 trimethylation(GO:1900113) |
0.1 | 1.1 | GO:0006517 | protein deglycosylation(GO:0006517) |
0.1 | 0.2 | GO:0032831 | regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0032829) positive regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0032831) |
0.1 | 0.2 | GO:0032415 | regulation of sodium:proton antiporter activity(GO:0032415) |
0.1 | 0.4 | GO:1904354 | negative regulation of telomere capping(GO:1904354) |
0.1 | 0.9 | GO:0021670 | lateral ventricle development(GO:0021670) |
0.1 | 0.8 | GO:0032790 | ribosome disassembly(GO:0032790) |
0.1 | 0.3 | GO:0090292 | nuclear matrix organization(GO:0043578) nuclear matrix anchoring at nuclear membrane(GO:0090292) |
0.1 | 0.4 | GO:0060384 | innervation(GO:0060384) |
0.1 | 0.3 | GO:0046391 | 5-phosphoribose 1-diphosphate biosynthetic process(GO:0006015) 5-phosphoribose 1-diphosphate metabolic process(GO:0046391) |
0.1 | 0.4 | GO:0010989 | negative regulation of low-density lipoprotein particle clearance(GO:0010989) |
0.1 | 0.1 | GO:1902083 | negative regulation of peptidyl-cysteine S-nitrosylation(GO:1902083) |
0.1 | 0.6 | GO:0002756 | MyD88-independent toll-like receptor signaling pathway(GO:0002756) |
0.1 | 0.3 | GO:0008626 | granzyme-mediated apoptotic signaling pathway(GO:0008626) |
0.1 | 0.1 | GO:0071481 | cellular response to X-ray(GO:0071481) |
0.1 | 0.1 | GO:1900020 | regulation of protein kinase C activity(GO:1900019) positive regulation of protein kinase C activity(GO:1900020) |
0.1 | 0.3 | GO:0003241 | growth involved in heart morphogenesis(GO:0003241) |
0.1 | 0.2 | GO:0034242 | negative regulation of syncytium formation by plasma membrane fusion(GO:0034242) |
0.1 | 0.9 | GO:0031167 | rRNA methylation(GO:0031167) |
0.1 | 0.6 | GO:0070307 | lens fiber cell development(GO:0070307) |
0.1 | 2.8 | GO:0043252 | sodium-independent organic anion transport(GO:0043252) |
0.1 | 0.2 | GO:0070268 | cornification(GO:0070268) |
0.1 | 0.3 | GO:0006562 | proline catabolic process(GO:0006562) |
0.1 | 0.3 | GO:0000710 | meiotic mismatch repair(GO:0000710) |
0.1 | 0.4 | GO:0070295 | renal water absorption(GO:0070295) |
0.1 | 0.1 | GO:0035524 | proline transmembrane transport(GO:0035524) |
0.1 | 0.5 | GO:0071073 | positive regulation of phospholipid biosynthetic process(GO:0071073) |
0.1 | 1.6 | GO:0045742 | positive regulation of epidermal growth factor receptor signaling pathway(GO:0045742) positive regulation of ERBB signaling pathway(GO:1901186) |
0.1 | 0.3 | GO:0072318 | clathrin coat disassembly(GO:0072318) |
0.1 | 0.1 | GO:0086028 | bundle of His cell to Purkinje myocyte signaling(GO:0086028) bundle of His cell action potential(GO:0086043) |
0.1 | 0.1 | GO:0099625 | regulation of ventricular cardiac muscle cell membrane repolarization(GO:0060307) ventricular cardiac muscle cell membrane repolarization(GO:0099625) |
0.1 | 0.2 | GO:0099612 | protein localization to axon(GO:0099612) |
0.1 | 0.4 | GO:0003406 | retinal pigment epithelium development(GO:0003406) |
0.1 | 0.2 | GO:0001705 | ectoderm formation(GO:0001705) |
0.1 | 1.4 | GO:0045956 | positive regulation of calcium ion-dependent exocytosis(GO:0045956) |
0.1 | 0.3 | GO:0036112 | medium-chain fatty-acyl-CoA metabolic process(GO:0036112) |
0.1 | 0.1 | GO:0006931 | substrate-dependent cell migration, cell attachment to substrate(GO:0006931) |
0.1 | 0.3 | GO:0045719 | negative regulation of glycogen biosynthetic process(GO:0045719) |
0.1 | 0.3 | GO:0010897 | negative regulation of triglyceride catabolic process(GO:0010897) |
0.1 | 0.2 | GO:0006772 | thiamine metabolic process(GO:0006772) thiamine-containing compound metabolic process(GO:0042723) |
0.1 | 0.6 | GO:0048251 | elastic fiber assembly(GO:0048251) |
0.1 | 0.6 | GO:0032570 | response to progesterone(GO:0032570) |
0.1 | 1.7 | GO:0051443 | positive regulation of ubiquitin-protein transferase activity(GO:0051443) |
0.1 | 0.2 | GO:0045423 | granulocyte macrophage colony-stimulating factor biosynthetic process(GO:0042253) regulation of granulocyte macrophage colony-stimulating factor biosynthetic process(GO:0045423) |
0.1 | 0.4 | GO:0015816 | glycine transport(GO:0015816) |
0.1 | 0.6 | GO:0071670 | smooth muscle cell chemotaxis(GO:0071670) |
0.1 | 0.5 | GO:0097084 | vascular smooth muscle cell development(GO:0097084) |
0.1 | 2.0 | GO:1901379 | regulation of potassium ion transmembrane transport(GO:1901379) |
0.1 | 0.3 | GO:0045409 | negative regulation of interleukin-6 biosynthetic process(GO:0045409) |
0.1 | 0.7 | GO:0071542 | dopaminergic neuron differentiation(GO:0071542) |
0.1 | 0.3 | GO:0032483 | regulation of Rab protein signal transduction(GO:0032483) |
0.1 | 0.4 | GO:0015808 | L-alanine transport(GO:0015808) |
0.1 | 0.1 | GO:0070672 | response to interleukin-15(GO:0070672) |
0.1 | 0.3 | GO:0034316 | negative regulation of Arp2/3 complex-mediated actin nucleation(GO:0034316) |
0.1 | 0.2 | GO:0002727 | natural killer cell cytokine production(GO:0002370) regulation of natural killer cell cytokine production(GO:0002727) |
0.1 | 0.8 | GO:0070189 | kynurenine metabolic process(GO:0070189) |
0.1 | 0.3 | GO:0090611 | ubiquitin-independent protein catabolic process via the multivesicular body sorting pathway(GO:0090611) |
0.1 | 0.1 | GO:0097476 | motor neuron migration(GO:0097475) spinal cord motor neuron migration(GO:0097476) |
0.1 | 0.2 | GO:0060126 | somatotropin secreting cell differentiation(GO:0060126) |
0.1 | 0.4 | GO:2000623 | regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000622) negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000623) |
0.1 | 0.2 | GO:0086026 | atrial cardiac muscle cell action potential(GO:0086014) atrial cardiac muscle cell to AV node cell signaling(GO:0086026) atrial cardiac muscle cell to AV node cell communication(GO:0086066) |
0.1 | 0.2 | GO:0002430 | complement receptor mediated signaling pathway(GO:0002430) |
0.1 | 0.4 | GO:0036233 | glycine import(GO:0036233) |
0.1 | 0.9 | GO:2000479 | regulation of cAMP-dependent protein kinase activity(GO:2000479) |
0.1 | 0.3 | GO:0018343 | protein farnesylation(GO:0018343) |
0.1 | 0.6 | GO:0060231 | mesenchymal to epithelial transition(GO:0060231) |
0.1 | 0.4 | GO:0071569 | protein ufmylation(GO:0071569) protein polyufmylation(GO:1990564) protein K69-linked ufmylation(GO:1990592) |
0.1 | 0.2 | GO:1903334 | positive regulation of protein folding(GO:1903334) |
0.1 | 0.3 | GO:1901874 | regulation of post-translational protein modification(GO:1901873) negative regulation of post-translational protein modification(GO:1901874) |
0.1 | 0.4 | GO:0033234 | negative regulation of protein sumoylation(GO:0033234) |
0.1 | 0.7 | GO:0002329 | pre-B cell differentiation(GO:0002329) |
0.1 | 0.1 | GO:0014050 | negative regulation of glutamate secretion(GO:0014050) |
0.1 | 0.2 | GO:0090370 | negative regulation of cholesterol efflux(GO:0090370) |
0.1 | 0.2 | GO:0071677 | positive regulation of mononuclear cell migration(GO:0071677) |
0.1 | 0.1 | GO:0060112 | generation of ovulation cycle rhythm(GO:0060112) |
0.1 | 0.2 | GO:0034395 | regulation of transcription from RNA polymerase II promoter in response to iron(GO:0034395) |
0.1 | 0.1 | GO:0071898 | regulation of estrogen receptor binding(GO:0071898) negative regulation of estrogen receptor binding(GO:0071899) |
0.1 | 0.2 | GO:0097384 | ether lipid biosynthetic process(GO:0008611) glycerol ether biosynthetic process(GO:0046504) cellular lipid biosynthetic process(GO:0097384) ether biosynthetic process(GO:1901503) |
0.1 | 1.4 | GO:0010765 | positive regulation of sodium ion transport(GO:0010765) |
0.1 | 0.4 | GO:0008334 | histone mRNA metabolic process(GO:0008334) |
0.1 | 0.1 | GO:0035907 | dorsal aorta development(GO:0035907) dorsal aorta morphogenesis(GO:0035912) |
0.1 | 0.1 | GO:0090500 | endocardial cushion to mesenchymal transition(GO:0090500) |
0.1 | 0.4 | GO:0043615 | astrocyte cell migration(GO:0043615) |
0.1 | 0.1 | GO:0009436 | glyoxylate catabolic process(GO:0009436) |
0.1 | 0.3 | GO:0060484 | lung-associated mesenchyme development(GO:0060484) |
0.1 | 1.8 | GO:0030199 | collagen fibril organization(GO:0030199) |
0.1 | 0.4 | GO:0051415 | interphase microtubule nucleation by interphase microtubule organizing center(GO:0051415) microtubule nucleation by microtubule organizing center(GO:0051418) |
0.1 | 0.1 | GO:0060024 | rhythmic synaptic transmission(GO:0060024) |
0.1 | 0.7 | GO:0016926 | protein desumoylation(GO:0016926) |
0.1 | 0.7 | GO:1901072 | glucosamine-containing compound catabolic process(GO:1901072) |
0.1 | 0.3 | GO:0061370 | testosterone biosynthetic process(GO:0061370) |
0.1 | 0.1 | GO:0003419 | growth plate cartilage chondrocyte proliferation(GO:0003419) |
0.1 | 0.1 | GO:0007171 | activation of transmembrane receptor protein tyrosine kinase activity(GO:0007171) |
0.1 | 0.1 | GO:0061038 | uterus morphogenesis(GO:0061038) |
0.1 | 0.3 | GO:0046416 | D-amino acid metabolic process(GO:0046416) |
0.1 | 0.6 | GO:0005981 | regulation of glycogen catabolic process(GO:0005981) |
0.1 | 0.1 | GO:0070827 | chromatin maintenance(GO:0070827) |
0.1 | 0.1 | GO:0010958 | regulation of amino acid import(GO:0010958) regulation of L-arginine import(GO:0010963) |
0.1 | 0.4 | GO:0042756 | drinking behavior(GO:0042756) |
0.1 | 0.2 | GO:0009597 | detection of virus(GO:0009597) |
0.1 | 0.2 | GO:2000467 | positive regulation of glycogen (starch) synthase activity(GO:2000467) |
0.1 | 0.2 | GO:0070164 | negative regulation of adiponectin secretion(GO:0070164) |
0.1 | 0.1 | GO:0033087 | negative regulation of immature T cell proliferation(GO:0033087) |
0.1 | 0.3 | GO:0019227 | neuronal action potential propagation(GO:0019227) action potential propagation(GO:0098870) |
0.1 | 0.6 | GO:0046697 | decidualization(GO:0046697) |
0.1 | 0.1 | GO:0009093 | cysteine catabolic process(GO:0009093) L-cysteine catabolic process(GO:0019448) L-cysteine metabolic process(GO:0046439) |
0.1 | 0.3 | GO:0071236 | cellular response to antibiotic(GO:0071236) |
0.1 | 0.2 | GO:0042997 | negative regulation of Golgi to plasma membrane protein transport(GO:0042997) |
0.1 | 0.2 | GO:0015889 | cobalamin transport(GO:0015889) |
0.1 | 0.6 | GO:0000463 | maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000463) |
0.1 | 0.2 | GO:1903774 | positive regulation of viral budding via host ESCRT complex(GO:1903774) |
0.1 | 1.1 | GO:0006144 | purine nucleobase metabolic process(GO:0006144) |
0.1 | 0.2 | GO:0042167 | heme catabolic process(GO:0042167) pigment catabolic process(GO:0046149) |
0.1 | 0.8 | GO:0032967 | positive regulation of collagen biosynthetic process(GO:0032967) |
0.1 | 0.3 | GO:0007621 | negative regulation of female receptivity(GO:0007621) |
0.1 | 0.3 | GO:0042754 | negative regulation of circadian rhythm(GO:0042754) |
0.1 | 0.1 | GO:0072201 | negative regulation of mesenchymal cell proliferation(GO:0072201) |
0.1 | 0.3 | GO:0031953 | negative regulation of protein autophosphorylation(GO:0031953) |
0.1 | 0.2 | GO:0014072 | response to isoquinoline alkaloid(GO:0014072) response to morphine(GO:0043278) |
0.1 | 0.3 | GO:0030903 | notochord development(GO:0030903) |
0.1 | 0.3 | GO:1900364 | negative regulation of mRNA polyadenylation(GO:1900364) |
0.1 | 0.1 | GO:0035694 | mitochondrial protein catabolic process(GO:0035694) |
0.1 | 0.1 | GO:0002767 | immune response-inhibiting cell surface receptor signaling pathway(GO:0002767) |
0.1 | 0.1 | GO:0002035 | brain renin-angiotensin system(GO:0002035) |
0.1 | 0.2 | GO:0032959 | inositol trisphosphate biosynthetic process(GO:0032959) |
0.1 | 0.2 | GO:0006177 | GMP biosynthetic process(GO:0006177) |
0.1 | 0.1 | GO:1904180 | negative regulation of mitochondrial depolarization(GO:0051902) negative regulation of membrane depolarization(GO:1904180) |
0.1 | 0.2 | GO:1904424 | regulation of GTP binding(GO:1904424) |
0.1 | 1.0 | GO:0001958 | endochondral ossification(GO:0001958) replacement ossification(GO:0036075) |
0.1 | 0.1 | GO:2000574 | regulation of microtubule motor activity(GO:2000574) |
0.1 | 0.1 | GO:0000101 | sulfur amino acid transport(GO:0000101) |
0.1 | 0.1 | GO:0006982 | response to lipid hydroperoxide(GO:0006982) |
0.1 | 0.1 | GO:2000852 | corticosterone secretion(GO:0035934) regulation of corticosterone secretion(GO:2000852) |
0.1 | 0.2 | GO:0060836 | lymphatic endothelial cell differentiation(GO:0060836) |
0.1 | 0.1 | GO:0060762 | regulation of branching involved in mammary gland duct morphogenesis(GO:0060762) |
0.1 | 0.2 | GO:0018125 | peptidyl-cysteine methylation(GO:0018125) |
0.1 | 0.1 | GO:0060478 | acrosomal vesicle exocytosis(GO:0060478) |
0.1 | 0.4 | GO:0031936 | negative regulation of chromatin silencing(GO:0031936) |
0.1 | 0.1 | GO:0072205 | metanephric collecting duct development(GO:0072205) |
0.1 | 0.1 | GO:1902221 | L-phenylalanine metabolic process(GO:0006558) erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process(GO:1902221) |
0.1 | 0.3 | GO:0006307 | DNA dealkylation involved in DNA repair(GO:0006307) |
0.1 | 0.2 | GO:0070120 | ciliary neurotrophic factor-mediated signaling pathway(GO:0070120) |
0.1 | 0.2 | GO:0043589 | skin morphogenesis(GO:0043589) |
0.1 | 0.7 | GO:0030322 | stabilization of membrane potential(GO:0030322) |
0.1 | 0.2 | GO:0070537 | histone H2A K63-linked deubiquitination(GO:0070537) |
0.1 | 0.6 | GO:0019377 | glycolipid catabolic process(GO:0019377) |
0.1 | 0.2 | GO:0006363 | termination of RNA polymerase I transcription(GO:0006363) |
0.1 | 0.3 | GO:0045144 | meiotic sister chromatid segregation(GO:0045144) meiotic sister chromatid cohesion(GO:0051177) |
0.1 | 1.4 | GO:0001825 | blastocyst formation(GO:0001825) |
0.1 | 2.9 | GO:0007270 | neuron-neuron synaptic transmission(GO:0007270) |
0.1 | 0.1 | GO:0044341 | sodium-dependent phosphate transport(GO:0044341) |
0.1 | 0.2 | GO:0009233 | menaquinone metabolic process(GO:0009233) |
0.1 | 0.1 | GO:0014744 | positive regulation of muscle adaptation(GO:0014744) |
0.1 | 0.3 | GO:0035269 | protein O-linked mannosylation(GO:0035269) |
0.1 | 0.7 | GO:0090083 | regulation of inclusion body assembly(GO:0090083) |
0.1 | 0.1 | GO:1901420 | negative regulation of response to alcohol(GO:1901420) |
0.1 | 0.1 | GO:0035973 | aggrephagy(GO:0035973) |
0.1 | 0.1 | GO:0019530 | taurine metabolic process(GO:0019530) |
0.1 | 0.2 | GO:0002689 | negative regulation of leukocyte chemotaxis(GO:0002689) |
0.1 | 0.3 | GO:0097152 | mesenchymal cell apoptotic process(GO:0097152) |
0.1 | 0.1 | GO:1902514 | regulation of calcium ion transmembrane transport via high voltage-gated calcium channel(GO:1902514) |
0.1 | 0.1 | GO:0060467 | negative regulation of fertilization(GO:0060467) |
0.1 | 0.2 | GO:2000255 | negative regulation of male germ cell proliferation(GO:2000255) |
0.1 | 0.1 | GO:0060459 | left lung development(GO:0060459) left lung morphogenesis(GO:0060460) |
0.1 | 0.1 | GO:0009313 | oligosaccharide catabolic process(GO:0009313) |
0.1 | 0.2 | GO:0006296 | nucleotide-excision repair, DNA incision, 5'-to lesion(GO:0006296) |
0.1 | 0.2 | GO:0051684 | maintenance of Golgi location(GO:0051684) |
0.1 | 0.5 | GO:0007202 | activation of phospholipase C activity(GO:0007202) |
0.1 | 0.1 | GO:2000463 | positive regulation of excitatory postsynaptic potential(GO:2000463) |
0.1 | 0.1 | GO:0072683 | T cell extravasation(GO:0072683) regulation of T cell extravasation(GO:2000407) positive regulation of T cell extravasation(GO:2000409) |
0.0 | 0.3 | GO:0045779 | negative regulation of bone resorption(GO:0045779) |
0.0 | 0.1 | GO:0010847 | regulation of chromatin assembly(GO:0010847) |
0.0 | 0.1 | GO:0090038 | negative regulation of protein kinase C signaling(GO:0090038) |
0.0 | 0.2 | GO:0002778 | antimicrobial peptide production(GO:0002775) antibacterial peptide production(GO:0002778) |
0.0 | 0.1 | GO:0048341 | paraxial mesoderm formation(GO:0048341) |
0.0 | 0.8 | GO:0001574 | ganglioside biosynthetic process(GO:0001574) |
0.0 | 0.0 | GO:0042713 | sperm ejaculation(GO:0042713) |
0.0 | 0.2 | GO:0035640 | exploration behavior(GO:0035640) |
0.0 | 0.3 | GO:0035234 | ectopic germ cell programmed cell death(GO:0035234) |
0.0 | 0.3 | GO:0002318 | myeloid progenitor cell differentiation(GO:0002318) |
0.0 | 0.2 | GO:0021542 | dentate gyrus development(GO:0021542) |
0.0 | 0.0 | GO:0030950 | establishment or maintenance of actin cytoskeleton polarity(GO:0030950) |
0.0 | 0.7 | GO:0016242 | negative regulation of macroautophagy(GO:0016242) |
0.0 | 0.1 | GO:0007468 | regulation of rhodopsin gene expression(GO:0007468) |
0.0 | 0.0 | GO:0036091 | positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0036091) |
0.0 | 0.1 | GO:0048852 | diencephalon morphogenesis(GO:0048852) |
0.0 | 0.1 | GO:0032957 | inositol trisphosphate metabolic process(GO:0032957) |
0.0 | 0.2 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
0.0 | 0.1 | GO:0001976 | neurological system process involved in regulation of systemic arterial blood pressure(GO:0001976) |
0.0 | 0.1 | GO:1990705 | cholangiocyte proliferation(GO:1990705) |
0.0 | 0.1 | GO:0045869 | negative regulation of single stranded viral RNA replication via double stranded DNA intermediate(GO:0045869) |
0.0 | 0.1 | GO:0000436 | carbon catabolite regulation of transcription from RNA polymerase II promoter(GO:0000429) carbon catabolite activation of transcription from RNA polymerase II promoter(GO:0000436) carbon catabolite activation of transcription(GO:0045991) |
0.0 | 0.1 | GO:1902202 | regulation of hepatocyte growth factor receptor signaling pathway(GO:1902202) |
0.0 | 0.1 | GO:0097105 | presynaptic membrane assembly(GO:0097105) |
0.0 | 0.1 | GO:1902071 | regulation of hypoxia-inducible factor-1alpha signaling pathway(GO:1902071) |
0.0 | 0.0 | GO:0035482 | gastric motility(GO:0035482) |
0.0 | 0.2 | GO:2000310 | regulation of N-methyl-D-aspartate selective glutamate receptor activity(GO:2000310) |
0.0 | 0.2 | GO:0035235 | ionotropic glutamate receptor signaling pathway(GO:0035235) |
0.0 | 0.2 | GO:0070863 | positive regulation of protein exit from endoplasmic reticulum(GO:0070863) |
0.0 | 0.1 | GO:0014043 | negative regulation of neuron maturation(GO:0014043) |
0.0 | 0.2 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
0.0 | 0.3 | GO:0043374 | CD8-positive, alpha-beta T cell differentiation(GO:0043374) |
0.0 | 0.2 | GO:0043654 | recognition of apoptotic cell(GO:0043654) |
0.0 | 0.3 | GO:0033523 | histone H2B ubiquitination(GO:0033523) |
0.0 | 0.2 | GO:0072498 | embryonic skeletal joint development(GO:0072498) |
0.0 | 0.1 | GO:0035526 | retrograde transport, plasma membrane to Golgi(GO:0035526) |
0.0 | 1.1 | GO:0007019 | microtubule depolymerization(GO:0007019) |
0.0 | 0.1 | GO:0038161 | prolactin signaling pathway(GO:0038161) |
0.0 | 0.0 | GO:0038065 | collagen-activated signaling pathway(GO:0038065) |
0.0 | 0.3 | GO:0007144 | female meiosis I(GO:0007144) |
0.0 | 0.1 | GO:0044339 | canonical Wnt signaling pathway involved in osteoblast differentiation(GO:0044339) |
0.0 | 0.1 | GO:0034239 | regulation of macrophage fusion(GO:0034239) |
0.0 | 0.1 | GO:0006566 | threonine metabolic process(GO:0006566) |
0.0 | 0.0 | GO:0008065 | establishment of blood-nerve barrier(GO:0008065) |
0.0 | 0.1 | GO:0097067 | cellular response to thyroid hormone stimulus(GO:0097067) |
0.0 | 0.1 | GO:2000659 | regulation of interleukin-1-mediated signaling pathway(GO:2000659) |
0.0 | 0.1 | GO:1901491 | negative regulation of lymphangiogenesis(GO:1901491) |
0.0 | 0.1 | GO:1902913 | positive regulation of neuroepithelial cell differentiation(GO:1902913) |
0.0 | 0.9 | GO:0046039 | GTP metabolic process(GO:0046039) |
0.0 | 0.2 | GO:0042256 | mature ribosome assembly(GO:0042256) |
0.0 | 0.0 | GO:0021747 | cochlear nucleus development(GO:0021747) |
0.0 | 0.2 | GO:0001514 | selenocysteine incorporation(GO:0001514) translational readthrough(GO:0006451) |
0.0 | 0.2 | GO:0051534 | negative regulation of NFAT protein import into nucleus(GO:0051534) |
0.0 | 0.3 | GO:0001553 | luteinization(GO:0001553) |
0.0 | 0.3 | GO:0035745 | CD4-positive, alpha-beta T cell cytokine production(GO:0035743) T-helper 2 cell cytokine production(GO:0035745) |
0.0 | 0.0 | GO:0071492 | cellular response to UV-A(GO:0071492) |
0.0 | 0.4 | GO:0032695 | negative regulation of interleukin-12 production(GO:0032695) |
0.0 | 0.1 | GO:0010360 | negative regulation of anion channel activity(GO:0010360) |
0.0 | 0.0 | GO:0045041 | protein import into mitochondrial intermembrane space(GO:0045041) |
0.0 | 0.1 | GO:0000389 | mRNA 3'-splice site recognition(GO:0000389) |
0.0 | 0.0 | GO:0060492 | foregut regionalization(GO:0060423) lung field specification(GO:0060424) lung induction(GO:0060492) |
0.0 | 0.0 | GO:0035964 | COPI-coated vesicle budding(GO:0035964) |
0.0 | 0.0 | GO:0048696 | collateral sprouting in absence of injury(GO:0048669) regulation of collateral sprouting in absence of injury(GO:0048696) |
0.0 | 0.0 | GO:0010749 | regulation of nitric oxide mediated signal transduction(GO:0010749) |
0.0 | 0.1 | GO:0038028 | insulin receptor signaling pathway via phosphatidylinositol 3-kinase(GO:0038028) |
0.0 | 0.3 | GO:0034389 | lipid particle organization(GO:0034389) |
0.0 | 0.1 | GO:0060278 | regulation of ovulation(GO:0060278) positive regulation of ovulation(GO:0060279) |
0.0 | 0.1 | GO:0046015 | regulation of transcription by glucose(GO:0046015) |
0.0 | 0.0 | GO:0070671 | response to interleukin-12(GO:0070671) |
0.0 | 0.0 | GO:0060013 | righting reflex(GO:0060013) |
0.0 | 0.0 | GO:0002525 | acute inflammatory response to non-antigenic stimulus(GO:0002525) |
0.0 | 0.0 | GO:0019364 | pyridine nucleotide catabolic process(GO:0019364) |
0.0 | 0.1 | GO:0007089 | traversing start control point of mitotic cell cycle(GO:0007089) |
0.0 | 0.1 | GO:0021563 | glossopharyngeal nerve development(GO:0021563) |
0.0 | 0.1 | GO:0071225 | cellular response to muramyl dipeptide(GO:0071225) |
0.0 | 0.1 | GO:0030242 | pexophagy(GO:0030242) |
0.0 | 0.1 | GO:2000382 | positive regulation of mesoderm development(GO:2000382) |
0.0 | 0.0 | GO:1902455 | negative regulation of stem cell population maintenance(GO:1902455) |
0.0 | 0.3 | GO:1900004 | regulation of serine-type endopeptidase activity(GO:1900003) negative regulation of serine-type endopeptidase activity(GO:1900004) regulation of serine-type peptidase activity(GO:1902571) negative regulation of serine-type peptidase activity(GO:1902572) |
0.0 | 0.4 | GO:0090382 | phagosome maturation(GO:0090382) |
0.0 | 0.6 | GO:0030890 | positive regulation of B cell proliferation(GO:0030890) |
0.0 | 0.1 | GO:0048012 | hepatocyte growth factor receptor signaling pathway(GO:0048012) |
0.0 | 0.2 | GO:0090671 | RNA localization to Cajal body(GO:0090670) telomerase RNA localization to Cajal body(GO:0090671) telomerase RNA localization(GO:0090672) |
0.0 | 0.1 | GO:0030208 | dermatan sulfate biosynthetic process(GO:0030208) |
0.0 | 1.0 | GO:0033139 | regulation of peptidyl-serine phosphorylation of STAT protein(GO:0033139) |
0.0 | 0.1 | GO:0031339 | negative regulation of vesicle fusion(GO:0031339) |
0.0 | 0.1 | GO:0006001 | fructose catabolic process(GO:0006001) fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate(GO:0061624) glycolytic process through fructose-1-phosphate(GO:0061625) |
0.0 | 0.4 | GO:0070208 | protein heterotrimerization(GO:0070208) |
0.0 | 0.1 | GO:0043987 | histone H3-S10 phosphorylation(GO:0043987) |
0.0 | 0.2 | GO:0060670 | branching involved in labyrinthine layer morphogenesis(GO:0060670) |
0.0 | 0.2 | GO:0006108 | malate metabolic process(GO:0006108) |
0.0 | 0.0 | GO:0060399 | positive regulation of growth hormone receptor signaling pathway(GO:0060399) |
0.0 | 0.1 | GO:1902626 | assembly of large subunit precursor of preribosome(GO:1902626) |
0.0 | 0.0 | GO:0097278 | complement-dependent cytotoxicity(GO:0097278) |
0.0 | 0.1 | GO:1901857 | positive regulation of cellular respiration(GO:1901857) |
0.0 | 0.0 | GO:0070669 | response to interleukin-2(GO:0070669) |
0.0 | 0.1 | GO:0010587 | miRNA catabolic process(GO:0010587) |
0.0 | 0.0 | GO:0046985 | positive regulation of hemoglobin biosynthetic process(GO:0046985) |
0.0 | 0.1 | GO:0032875 | regulation of DNA endoreduplication(GO:0032875) |
0.0 | 0.1 | GO:0046548 | retinal rod cell development(GO:0046548) |
0.0 | 0.0 | GO:0000255 | allantoin metabolic process(GO:0000255) |
0.0 | 0.0 | GO:0097070 | ductus arteriosus closure(GO:0097070) |
0.0 | 0.0 | GO:0034146 | toll-like receptor 5 signaling pathway(GO:0034146) |
0.0 | 0.0 | GO:0032988 | ribonucleoprotein complex disassembly(GO:0032988) |
0.0 | 0.0 | GO:1903772 | regulation of viral budding via host ESCRT complex(GO:1903772) |
0.0 | 0.0 | GO:0090360 | platelet-derived growth factor production(GO:0090360) regulation of platelet-derived growth factor production(GO:0090361) |
0.0 | 0.1 | GO:0070423 | nucleotide-binding oligomerization domain containing signaling pathway(GO:0070423) nucleotide-binding oligomerization domain containing 2 signaling pathway(GO:0070431) |
0.0 | 0.0 | GO:0036151 | phosphatidylcholine acyl-chain remodeling(GO:0036151) |
0.0 | 0.2 | GO:0043508 | negative regulation of JUN kinase activity(GO:0043508) |
0.0 | 0.0 | GO:0021903 | rostrocaudal neural tube patterning(GO:0021903) |
0.0 | 0.1 | GO:0021884 | forebrain neuron development(GO:0021884) |
0.0 | 0.1 | GO:0021854 | hypothalamus development(GO:0021854) |
0.0 | 0.1 | GO:0035995 | detection of muscle stretch(GO:0035995) |
0.0 | 0.4 | GO:0071398 | cellular response to fatty acid(GO:0071398) |
0.0 | 0.0 | GO:0015838 | amino-acid betaine transport(GO:0015838) |
0.0 | 0.1 | GO:0044838 | cell quiescence(GO:0044838) |
0.0 | 0.5 | GO:0071300 | cellular response to retinoic acid(GO:0071300) |
0.0 | 0.1 | GO:0043152 | induction of bacterial agglutination(GO:0043152) |
0.0 | 0.1 | GO:0021554 | optic nerve development(GO:0021554) |
0.0 | 0.2 | GO:0035721 | intraciliary retrograde transport(GO:0035721) |
0.0 | 0.1 | GO:0000715 | nucleotide-excision repair, DNA damage recognition(GO:0000715) |
0.0 | 0.0 | GO:0090365 | regulation of mRNA modification(GO:0090365) |
0.0 | 0.1 | GO:0060011 | Sertoli cell proliferation(GO:0060011) |
0.0 | 0.1 | GO:0045217 | cell-cell junction maintenance(GO:0045217) |
0.0 | 0.1 | GO:0009235 | cobalamin metabolic process(GO:0009235) |
0.0 | 0.2 | GO:1900118 | negative regulation of execution phase of apoptosis(GO:1900118) |
0.0 | 0.1 | GO:0090166 | Golgi disassembly(GO:0090166) |
0.0 | 0.0 | GO:0071233 | response to leucine(GO:0043201) cellular response to leucine(GO:0071233) |
0.0 | 0.0 | GO:0086015 | SA node cell action potential(GO:0086015) SA node cell to atrial cardiac muscle cell signalling(GO:0086018) SA node cell to atrial cardiac muscle cell communication(GO:0086070) |
0.0 | 0.0 | GO:0014012 | peripheral nervous system axon regeneration(GO:0014012) |
0.0 | 0.0 | GO:0045002 | double-strand break repair via single-strand annealing(GO:0045002) |
0.0 | 0.2 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
0.0 | 0.2 | GO:0045899 | positive regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0045899) |
0.0 | 0.0 | GO:0032308 | positive regulation of prostaglandin secretion(GO:0032308) |
0.0 | 0.0 | GO:0021877 | forebrain neuron fate commitment(GO:0021877) |
0.0 | 0.1 | GO:0019042 | viral latency(GO:0019042) |
0.0 | 0.0 | GO:0002069 | columnar/cuboidal epithelial cell maturation(GO:0002069) |
0.0 | 0.0 | GO:0021603 | cranial nerve formation(GO:0021603) |
0.0 | 0.1 | GO:0045900 | negative regulation of translational elongation(GO:0045900) |
0.0 | 0.1 | GO:0033499 | galactose catabolic process via UDP-galactose(GO:0033499) glycolytic process from galactose(GO:0061623) |
0.0 | 0.1 | GO:0000270 | peptidoglycan metabolic process(GO:0000270) peptidoglycan catabolic process(GO:0009253) |
0.0 | 0.2 | GO:0046688 | response to copper ion(GO:0046688) |
0.0 | 0.0 | GO:2000173 | negative regulation of branching morphogenesis of a nerve(GO:2000173) |
0.0 | 0.1 | GO:0038031 | non-canonical Wnt signaling pathway via MAPK cascade(GO:0038030) non-canonical Wnt signaling pathway via JNK cascade(GO:0038031) |
0.0 | 0.1 | GO:0050689 | negative regulation of defense response to virus by host(GO:0050689) |
0.0 | 0.1 | GO:0033683 | nucleotide-excision repair, DNA incision(GO:0033683) |
0.0 | 0.0 | GO:0048069 | eye pigmentation(GO:0048069) |
0.0 | 0.0 | GO:0071038 | nuclear polyadenylation-dependent tRNA catabolic process(GO:0071038) |
0.0 | 0.1 | GO:0019254 | carnitine metabolic process, CoA-linked(GO:0019254) |
0.0 | 0.0 | GO:0070508 | sterol import(GO:0035376) cholesterol import(GO:0070508) |
0.0 | 0.1 | GO:0006297 | nucleotide-excision repair, DNA gap filling(GO:0006297) |
0.0 | 0.1 | GO:0071499 | response to laminar fluid shear stress(GO:0034616) cellular response to laminar fluid shear stress(GO:0071499) |
0.0 | 0.1 | GO:0033152 | immunoglobulin V(D)J recombination(GO:0033152) |
0.0 | 0.2 | GO:0006656 | phosphatidylcholine biosynthetic process(GO:0006656) |
0.0 | 0.0 | GO:1903587 | regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:1903587) |
0.0 | 0.5 | GO:0042073 | intraciliary transport(GO:0042073) |
0.0 | 0.0 | GO:2000254 | regulation of male germ cell proliferation(GO:2000254) |
0.0 | 0.2 | GO:0060441 | epithelial tube branching involved in lung morphogenesis(GO:0060441) |
0.0 | 0.1 | GO:0045650 | negative regulation of macrophage differentiation(GO:0045650) |
0.0 | 0.1 | GO:0032825 | positive regulation of natural killer cell differentiation(GO:0032825) |
0.0 | 0.0 | GO:0070253 | somatostatin secretion(GO:0070253) |
0.0 | 0.1 | GO:0048743 | positive regulation of skeletal muscle fiber development(GO:0048743) |
0.0 | 0.0 | GO:0071896 | protein localization to adherens junction(GO:0071896) |
0.0 | 0.1 | GO:0086069 | bundle of His cell to Purkinje myocyte communication(GO:0086069) |
0.0 | 0.1 | GO:0032026 | response to magnesium ion(GO:0032026) |
0.0 | 0.0 | GO:0042758 | long-chain fatty acid catabolic process(GO:0042758) |
0.0 | 0.0 | GO:2001137 | positive regulation of endocytic recycling(GO:2001137) |
0.0 | 0.0 | GO:1900738 | positive regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900738) |
0.0 | 0.0 | GO:0002327 | immature B cell differentiation(GO:0002327) |
0.0 | 0.0 | GO:1904263 | positive regulation of TORC1 signaling(GO:1904263) |
0.0 | 0.1 | GO:0090161 | Golgi ribbon formation(GO:0090161) |
0.0 | 0.0 | GO:0006651 | diacylglycerol biosynthetic process(GO:0006651) |
0.0 | 0.0 | GO:0000720 | pyrimidine dimer repair by nucleotide-excision repair(GO:0000720) |
0.0 | 0.0 | GO:0071472 | cellular response to salt stress(GO:0071472) |
0.0 | 0.0 | GO:1902165 | regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:1902165) |
0.0 | 0.1 | GO:0016557 | peroxisome membrane biogenesis(GO:0016557) |
0.0 | 0.0 | GO:0060973 | cell migration involved in heart development(GO:0060973) |
0.0 | 0.0 | GO:2001032 | regulation of double-strand break repair via nonhomologous end joining(GO:2001032) |
0.0 | 0.1 | GO:0045686 | negative regulation of glial cell differentiation(GO:0045686) |
0.0 | 0.0 | GO:0014707 | branchiomeric skeletal muscle development(GO:0014707) |
0.0 | 0.0 | GO:0042222 | interleukin-1 biosynthetic process(GO:0042222) |
0.0 | 0.0 | GO:1900095 | regulation of dosage compensation by inactivation of X chromosome(GO:1900095) |
0.0 | 0.1 | GO:0042026 | protein refolding(GO:0042026) |
0.0 | 0.0 | GO:1903333 | negative regulation of protein folding(GO:1903333) |
0.0 | 0.1 | GO:0019228 | neuronal action potential(GO:0019228) |
0.0 | 0.0 | GO:0001573 | ganglioside metabolic process(GO:0001573) |
0.0 | 0.0 | GO:1990035 | calcium ion import into cell(GO:1990035) |
0.0 | 0.0 | GO:0072396 | response to cell cycle checkpoint signaling(GO:0072396) response to DNA integrity checkpoint signaling(GO:0072402) response to DNA damage checkpoint signaling(GO:0072423) response to intra-S DNA damage checkpoint signaling(GO:0072429) |
0.0 | 0.0 | GO:0000966 | RNA 5'-end processing(GO:0000966) |
0.0 | 0.1 | GO:0034497 | protein localization to pre-autophagosomal structure(GO:0034497) |
0.0 | 0.0 | GO:0033504 | floor plate development(GO:0033504) |
0.0 | 0.1 | GO:0044351 | macropinocytosis(GO:0044351) |
0.0 | 0.0 | GO:0070681 | glutaminyl-tRNAGln biosynthesis via transamidation(GO:0070681) |
0.0 | 0.0 | GO:1900368 | regulation of RNA interference(GO:1900368) |
0.0 | 0.0 | GO:1900227 | positive regulation of NLRP3 inflammasome complex assembly(GO:1900227) |
0.0 | 0.1 | GO:1990001 | inhibition of cysteine-type endopeptidase activity(GO:0097340) zymogen inhibition(GO:0097341) inhibition of cysteine-type endopeptidase activity involved in apoptotic process(GO:1990001) |
0.0 | 0.0 | GO:0035815 | positive regulation of renal sodium excretion(GO:0035815) |
0.0 | 0.0 | GO:1903232 | melanosome assembly(GO:1903232) |
0.0 | 0.0 | GO:0021571 | rhombomere 5 development(GO:0021571) |
0.0 | 0.1 | GO:0006348 | chromatin silencing at telomere(GO:0006348) |
0.0 | 0.0 | GO:1905049 | negative regulation of metalloendopeptidase activity(GO:1904684) negative regulation of metallopeptidase activity(GO:1905049) |
0.0 | 0.0 | GO:0060017 | parathyroid gland development(GO:0060017) |
0.0 | 0.0 | GO:2000035 | regulation of stem cell division(GO:2000035) |
0.0 | 0.1 | GO:0015871 | choline transport(GO:0015871) |
0.0 | 0.0 | GO:0035093 | spermatogenesis, exchange of chromosomal proteins(GO:0035093) |
0.0 | 0.0 | GO:0034638 | phosphatidylcholine catabolic process(GO:0034638) |
0.0 | 0.0 | GO:0006597 | spermine biosynthetic process(GO:0006597) |
0.0 | 0.0 | GO:0060743 | epithelial cell maturation involved in prostate gland development(GO:0060743) |
0.0 | 0.0 | GO:0018216 | peptidyl-arginine methylation(GO:0018216) |
0.0 | 0.0 | GO:0032747 | positive regulation of interleukin-23 production(GO:0032747) |
0.0 | 0.0 | GO:0009629 | response to gravity(GO:0009629) |
0.0 | 0.0 | GO:0006568 | tryptophan metabolic process(GO:0006568) indolalkylamine metabolic process(GO:0006586) |
0.0 | 0.0 | GO:0097411 | hypoxia-inducible factor-1alpha signaling pathway(GO:0097411) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.0 | 12.0 | GO:1990696 | USH2 complex(GO:1990696) |
2.0 | 20.2 | GO:0044224 | juxtaparanode region of axon(GO:0044224) |
1.7 | 6.9 | GO:0005968 | Rab-protein geranylgeranyltransferase complex(GO:0005968) |
1.3 | 3.8 | GO:1990812 | growth cone filopodium(GO:1990812) |
1.1 | 3.2 | GO:0060053 | neurofilament cytoskeleton(GO:0060053) |
1.0 | 12.4 | GO:0043194 | axon initial segment(GO:0043194) |
1.0 | 3.1 | GO:0072534 | perineuronal net(GO:0072534) |
0.8 | 2.3 | GO:0038037 | G-protein coupled receptor dimeric complex(GO:0038037) G-protein coupled receptor complex(GO:0097648) |
0.7 | 6.8 | GO:0070852 | cell body fiber(GO:0070852) |
0.7 | 8.1 | GO:0031512 | motile primary cilium(GO:0031512) |
0.6 | 3.1 | GO:0048787 | presynaptic active zone membrane(GO:0048787) |
0.6 | 5.4 | GO:0005883 | neurofilament(GO:0005883) |
0.6 | 2.9 | GO:0071547 | piP-body(GO:0071547) |
0.6 | 0.6 | GO:0070033 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin II complex(GO:0070033) |
0.5 | 4.9 | GO:0030673 | axolemma(GO:0030673) |
0.5 | 4.3 | GO:0071437 | invadopodium(GO:0071437) |
0.5 | 2.1 | GO:1990246 | uniplex complex(GO:1990246) |
0.5 | 1.5 | GO:0005914 | spot adherens junction(GO:0005914) |
0.5 | 3.0 | GO:0097342 | ripoptosome(GO:0097342) |
0.5 | 7.5 | GO:0016010 | dystrophin-associated glycoprotein complex(GO:0016010) glycoprotein complex(GO:0090665) |
0.5 | 1.4 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
0.4 | 1.3 | GO:0014701 | junctional sarcoplasmic reticulum membrane(GO:0014701) |
0.4 | 1.7 | GO:0044322 | endoplasmic reticulum quality control compartment(GO:0044322) |
0.4 | 6.8 | GO:0048786 | presynaptic active zone(GO:0048786) |
0.4 | 1.2 | GO:0031233 | intrinsic component of external side of plasma membrane(GO:0031233) |
0.4 | 4.1 | GO:0001518 | voltage-gated sodium channel complex(GO:0001518) |
0.4 | 19.8 | GO:0042734 | presynaptic membrane(GO:0042734) |
0.4 | 6.2 | GO:0001741 | XY body(GO:0001741) |
0.4 | 1.1 | GO:0043205 | fibril(GO:0043205) |
0.3 | 2.3 | GO:0017101 | aminoacyl-tRNA synthetase multienzyme complex(GO:0017101) |
0.3 | 2.3 | GO:0032584 | growth cone membrane(GO:0032584) |
0.3 | 5.5 | GO:0005614 | interstitial matrix(GO:0005614) |
0.3 | 1.8 | GO:0034991 | nuclear meiotic cohesin complex(GO:0034991) |
0.3 | 0.9 | GO:0090661 | box H/ACA telomerase RNP complex(GO:0090661) |
0.3 | 3.0 | GO:1990124 | messenger ribonucleoprotein complex(GO:1990124) |
0.3 | 3.2 | GO:0042555 | MCM complex(GO:0042555) |
0.3 | 1.7 | GO:0090571 | RNA polymerase II transcription repressor complex(GO:0090571) |
0.3 | 6.7 | GO:0030131 | clathrin adaptor complex(GO:0030131) |
0.3 | 0.6 | GO:0032280 | symmetric synapse(GO:0032280) |
0.3 | 3.0 | GO:0000346 | transcription export complex(GO:0000346) |
0.3 | 1.1 | GO:0035339 | SPOTS complex(GO:0035339) |
0.2 | 2.7 | GO:0001527 | microfibril(GO:0001527) |
0.2 | 0.2 | GO:0005879 | axonemal microtubule(GO:0005879) |
0.2 | 1.2 | GO:0044294 | dendritic growth cone(GO:0044294) |
0.2 | 0.7 | GO:0097451 | glial limiting end-foot(GO:0097451) |
0.2 | 0.7 | GO:0071008 | U2-type post-mRNA release spliceosomal complex(GO:0071008) |
0.2 | 0.7 | GO:0031074 | nucleocytoplasmic shuttling complex(GO:0031074) |
0.2 | 0.7 | GO:0005944 | phosphatidylinositol 3-kinase complex, class IB(GO:0005944) |
0.2 | 4.5 | GO:0032588 | trans-Golgi network membrane(GO:0032588) |
0.2 | 0.5 | GO:0070044 | synaptobrevin 2-SNAP-25-syntaxin-1a complex(GO:0070044) |
0.2 | 0.7 | GO:0036194 | muscle cell projection(GO:0036194) muscle cell projection membrane(GO:0036195) |
0.2 | 5.2 | GO:0034451 | centriolar satellite(GO:0034451) |
0.2 | 2.0 | GO:0002116 | semaphorin receptor complex(GO:0002116) |
0.2 | 6.6 | GO:0099501 | synaptic vesicle membrane(GO:0030672) exocytic vesicle membrane(GO:0099501) |
0.2 | 1.4 | GO:0043083 | synaptic cleft(GO:0043083) |
0.2 | 1.2 | GO:0035253 | ciliary rootlet(GO:0035253) |
0.2 | 0.8 | GO:0097169 | AIM2 inflammasome complex(GO:0097169) |
0.2 | 0.6 | GO:0032299 | ribonuclease H2 complex(GO:0032299) |
0.2 | 0.6 | GO:0034457 | Mpp10 complex(GO:0034457) |
0.2 | 1.6 | GO:0045275 | mitochondrial respiratory chain complex III(GO:0005750) respiratory chain complex III(GO:0045275) |
0.2 | 0.6 | GO:0005712 | chiasma(GO:0005712) |
0.2 | 1.5 | GO:0036156 | inner dynein arm(GO:0036156) |
0.2 | 1.0 | GO:0031428 | box C/D snoRNP complex(GO:0031428) |
0.2 | 1.0 | GO:0005672 | transcription factor TFIIA complex(GO:0005672) |
0.2 | 0.6 | GO:0035355 | Toll-like receptor 2-Toll-like receptor 6 protein complex(GO:0035355) |
0.2 | 2.6 | GO:0031430 | M band(GO:0031430) |
0.2 | 10.6 | GO:0008076 | voltage-gated potassium channel complex(GO:0008076) |
0.2 | 2.0 | GO:0031045 | dense core granule(GO:0031045) |
0.2 | 1.6 | GO:0032593 | insulin-responsive compartment(GO:0032593) |
0.2 | 1.6 | GO:0005832 | chaperonin-containing T-complex(GO:0005832) |
0.2 | 28.6 | GO:0045211 | postsynaptic membrane(GO:0045211) |
0.2 | 0.9 | GO:0071546 | pi-body(GO:0071546) |
0.2 | 0.3 | GO:0044316 | cone cell pedicle(GO:0044316) |
0.2 | 0.6 | GO:0030314 | junctional membrane complex(GO:0030314) |
0.2 | 0.8 | GO:0032009 | early phagosome(GO:0032009) |
0.2 | 0.5 | GO:0036454 | insulin-like growth factor binding protein complex(GO:0016942) growth factor complex(GO:0036454) insulin-like growth factor ternary complex(GO:0042567) |
0.2 | 0.9 | GO:0005915 | zonula adherens(GO:0005915) |
0.1 | 0.7 | GO:0016342 | catenin complex(GO:0016342) |
0.1 | 0.6 | GO:0005593 | FACIT collagen trimer(GO:0005593) |
0.1 | 0.8 | GO:0035032 | phosphatidylinositol 3-kinase complex, class III(GO:0035032) |
0.1 | 0.5 | GO:0000408 | EKC/KEOPS complex(GO:0000408) |
0.1 | 0.7 | GO:0060077 | inhibitory synapse(GO:0060077) |
0.1 | 0.3 | GO:0017146 | NMDA selective glutamate receptor complex(GO:0017146) |
0.1 | 1.3 | GO:0032426 | stereocilium tip(GO:0032426) |
0.1 | 17.9 | GO:0031225 | anchored component of membrane(GO:0031225) |
0.1 | 2.4 | GO:0005686 | U2 snRNP(GO:0005686) |
0.1 | 0.5 | GO:0000931 | gamma-tubulin large complex(GO:0000931) gamma-tubulin ring complex(GO:0008274) |
0.1 | 0.7 | GO:0031415 | NatA complex(GO:0031415) |
0.1 | 0.9 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
0.1 | 1.2 | GO:0045334 | clathrin-coated endocytic vesicle(GO:0045334) |
0.1 | 0.4 | GO:0031466 | Cul5-RING ubiquitin ligase complex(GO:0031466) |
0.1 | 0.7 | GO:0036057 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
0.1 | 1.2 | GO:0005847 | mRNA cleavage and polyadenylation specificity factor complex(GO:0005847) |
0.1 | 0.4 | GO:0071797 | LUBAC complex(GO:0071797) |
0.1 | 0.1 | GO:0097025 | MPP7-DLG1-LIN7 complex(GO:0097025) |
0.1 | 1.1 | GO:0005675 | holo TFIIH complex(GO:0005675) |
0.1 | 0.1 | GO:0035838 | growing cell tip(GO:0035838) |
0.1 | 0.3 | GO:0030127 | COPII vesicle coat(GO:0030127) |
0.1 | 0.4 | GO:0005851 | eukaryotic translation initiation factor 2B complex(GO:0005851) |
0.1 | 0.8 | GO:0042589 | zymogen granule membrane(GO:0042589) |
0.1 | 2.3 | GO:0031594 | neuromuscular junction(GO:0031594) |
0.1 | 0.3 | GO:0097433 | dense body(GO:0097433) |
0.1 | 7.7 | GO:0030426 | growth cone(GO:0030426) |
0.1 | 0.3 | GO:0017071 | intracellular cyclic nucleotide activated cation channel complex(GO:0017071) |
0.1 | 1.6 | GO:0035145 | exon-exon junction complex(GO:0035145) |
0.1 | 1.4 | GO:0098644 | complex of collagen trimers(GO:0098644) |
0.1 | 0.4 | GO:0001739 | sex chromatin(GO:0001739) |
0.1 | 0.2 | GO:0032937 | SREBP-SCAP-Insig complex(GO:0032937) |
0.1 | 0.2 | GO:0005608 | laminin-3 complex(GO:0005608) |
0.1 | 0.4 | GO:0070847 | core mediator complex(GO:0070847) |
0.1 | 0.1 | GO:0033268 | node of Ranvier(GO:0033268) |
0.1 | 0.2 | GO:0034274 | Atg12-Atg5-Atg16 complex(GO:0034274) |
0.1 | 0.2 | GO:0044530 | supraspliceosomal complex(GO:0044530) |
0.1 | 0.3 | GO:0043202 | lysosomal lumen(GO:0043202) |
0.1 | 0.2 | GO:0005785 | signal recognition particle receptor complex(GO:0005785) |
0.1 | 1.8 | GO:0032391 | photoreceptor connecting cilium(GO:0032391) |
0.1 | 0.2 | GO:0043511 | inhibin complex(GO:0043511) |
0.1 | 0.2 | GO:0031084 | BLOC-2 complex(GO:0031084) |
0.1 | 0.4 | GO:0071439 | clathrin complex(GO:0071439) |
0.1 | 0.5 | GO:0030991 | intraciliary transport particle A(GO:0030991) |
0.1 | 0.4 | GO:0031983 | vesicle lumen(GO:0031983) |
0.1 | 0.3 | GO:0070531 | BRCA1-A complex(GO:0070531) |
0.1 | 0.3 | GO:0030870 | Mre11 complex(GO:0030870) |
0.1 | 0.1 | GO:0032010 | phagolysosome(GO:0032010) |
0.1 | 0.2 | GO:0071001 | U4/U6 snRNP(GO:0071001) |
0.0 | 2.3 | GO:0043195 | terminal bouton(GO:0043195) |
0.0 | 0.1 | GO:0005958 | DNA-dependent protein kinase-DNA ligase 4 complex(GO:0005958) |
0.0 | 0.1 | GO:0005945 | 6-phosphofructokinase complex(GO:0005945) |
0.0 | 0.3 | GO:0030008 | TRAPP complex(GO:0030008) |
0.0 | 0.1 | GO:0010009 | cytoplasmic side of endosome membrane(GO:0010009) |
0.0 | 0.1 | GO:0005863 | striated muscle myosin thick filament(GO:0005863) |
0.0 | 1.9 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
0.0 | 0.1 | GO:0071953 | elastic fiber(GO:0071953) |
0.0 | 1.1 | GO:0000314 | organellar small ribosomal subunit(GO:0000314) mitochondrial small ribosomal subunit(GO:0005763) |
0.0 | 0.3 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
0.0 | 0.2 | GO:1990851 | Wnt-Frizzled-LRP5/6 complex(GO:1990851) |
0.0 | 0.1 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
0.0 | 0.1 | GO:0000110 | nucleotide-excision repair factor 1 complex(GO:0000110) |
0.0 | 0.4 | GO:0031597 | cytosolic proteasome complex(GO:0031597) |
0.0 | 0.1 | GO:0000811 | GINS complex(GO:0000811) |
0.0 | 0.3 | GO:0000137 | Golgi cis cisterna(GO:0000137) |
0.0 | 2.1 | GO:0022625 | cytosolic large ribosomal subunit(GO:0022625) |
0.0 | 0.8 | GO:0005790 | smooth endoplasmic reticulum(GO:0005790) |
0.0 | 0.1 | GO:0070939 | Dsl1p complex(GO:0070939) |
0.0 | 0.1 | GO:0042585 | germinal vesicle(GO:0042585) |
0.0 | 0.3 | GO:0032797 | SMN complex(GO:0032797) |
0.0 | 0.1 | GO:0031417 | NatC complex(GO:0031417) |
0.0 | 0.1 | GO:0005745 | m-AAA complex(GO:0005745) |
0.0 | 0.5 | GO:0042101 | T cell receptor complex(GO:0042101) |
0.0 | 0.1 | GO:0016600 | flotillin complex(GO:0016600) |
0.0 | 0.1 | GO:0097149 | centralspindlin complex(GO:0097149) |
0.0 | 0.1 | GO:0000805 | X chromosome(GO:0000805) |
0.0 | 0.1 | GO:0000796 | condensin complex(GO:0000796) |
0.0 | 0.1 | GO:0001674 | female germ cell nucleus(GO:0001674) |
0.0 | 0.2 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
0.0 | 0.1 | GO:0045252 | oxoglutarate dehydrogenase complex(GO:0045252) |
0.0 | 0.0 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
0.0 | 0.1 | GO:0071942 | XPC complex(GO:0071942) |
0.0 | 0.1 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
0.0 | 0.3 | GO:0046540 | U4/U6 x U5 tri-snRNP complex(GO:0046540) |
0.0 | 0.1 | GO:0089701 | U2AF(GO:0089701) |
0.0 | 0.0 | GO:0072588 | box H/ACA snoRNP complex(GO:0031429) box H/ACA RNP complex(GO:0072588) |
0.0 | 0.3 | GO:0000176 | nuclear exosome (RNase complex)(GO:0000176) |
0.0 | 0.1 | GO:0005658 | alpha DNA polymerase:primase complex(GO:0005658) |
0.0 | 0.4 | GO:0030057 | desmosome(GO:0030057) |
0.0 | 0.3 | GO:0035686 | sperm fibrous sheath(GO:0035686) |
0.0 | 0.2 | GO:0042587 | glycogen granule(GO:0042587) |
0.0 | 0.5 | GO:0005771 | multivesicular body(GO:0005771) |
0.0 | 0.1 | GO:0032444 | activin responsive factor complex(GO:0032444) |
0.0 | 0.1 | GO:0005826 | actomyosin contractile ring(GO:0005826) |
0.0 | 0.0 | GO:0072558 | NLRP1 inflammasome complex(GO:0072558) |
0.0 | 0.1 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
0.0 | 0.0 | GO:0000439 | core TFIIH complex(GO:0000439) |
0.0 | 0.1 | GO:0072557 | IPAF inflammasome complex(GO:0072557) |
0.0 | 0.1 | GO:0044615 | nuclear pore nuclear basket(GO:0044615) |
0.0 | 0.1 | GO:0005579 | membrane attack complex(GO:0005579) |
0.0 | 0.1 | GO:0034448 | EGO complex(GO:0034448) Gtr1-Gtr2 GTPase complex(GO:1990131) |
0.0 | 0.1 | GO:0005664 | origin recognition complex(GO:0000808) nuclear origin of replication recognition complex(GO:0005664) |
0.0 | 0.1 | GO:0000235 | astral microtubule(GO:0000235) |
0.0 | 0.0 | GO:0030956 | glutamyl-tRNA(Gln) amidotransferase complex(GO:0030956) |
0.0 | 0.1 | GO:0070419 | nonhomologous end joining complex(GO:0070419) |
0.0 | 0.1 | GO:0030134 | ER to Golgi transport vesicle(GO:0030134) |
0.0 | 0.6 | GO:0005581 | collagen trimer(GO:0005581) |
0.0 | 0.7 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
0.0 | 0.0 | GO:0030427 | site of polarized growth(GO:0030427) |
0.0 | 0.0 | GO:0033553 | rDNA heterochromatin(GO:0033553) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
4.1 | 12.3 | GO:0097109 | neuroligin family protein binding(GO:0097109) |
3.1 | 9.4 | GO:0000309 | nicotinamide-nucleotide adenylyltransferase activity(GO:0000309) nicotinate-nucleotide adenylyltransferase activity(GO:0004515) |
1.6 | 4.7 | GO:0048101 | calcium- and calmodulin-regulated 3',5'-cyclic-GMP phosphodiesterase activity(GO:0048101) |
1.4 | 4.2 | GO:0004427 | inorganic diphosphatase activity(GO:0004427) |
1.4 | 6.9 | GO:0030550 | acetylcholine receptor inhibitor activity(GO:0030550) |
1.4 | 8.1 | GO:0004385 | guanylate kinase activity(GO:0004385) |
1.3 | 5.3 | GO:0008502 | melatonin receptor activity(GO:0008502) |
1.2 | 3.6 | GO:1990825 | sequence-specific mRNA binding(GO:1990825) |
1.1 | 4.5 | GO:0004065 | arylsulfatase activity(GO:0004065) |
1.1 | 5.4 | GO:0051185 | coenzyme transporter activity(GO:0051185) |
1.1 | 6.4 | GO:0005049 | nuclear export signal receptor activity(GO:0005049) |
1.0 | 2.9 | GO:0004965 | G-protein coupled GABA receptor activity(GO:0004965) |
1.0 | 8.7 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
0.9 | 2.8 | GO:0055100 | adiponectin binding(GO:0055100) |
0.9 | 2.6 | GO:0004924 | oncostatin-M receptor activity(GO:0004924) |
0.8 | 2.5 | GO:0035373 | chondroitin sulfate proteoglycan binding(GO:0035373) |
0.8 | 3.2 | GO:0015183 | L-aspartate transmembrane transporter activity(GO:0015183) |
0.8 | 2.3 | GO:0004505 | phenylalanine 4-monooxygenase activity(GO:0004505) |
0.7 | 2.2 | GO:0097200 | cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:0097200) |
0.7 | 3.0 | GO:0097001 | ceramide binding(GO:0097001) |
0.7 | 3.7 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
0.7 | 2.9 | GO:0034584 | piRNA binding(GO:0034584) |
0.7 | 4.4 | GO:0004128 | cytochrome-b5 reductase activity, acting on NAD(P)H(GO:0004128) |
0.7 | 2.2 | GO:0016971 | flavin-linked sulfhydryl oxidase activity(GO:0016971) |
0.7 | 2.2 | GO:0004814 | arginine-tRNA ligase activity(GO:0004814) |
0.7 | 1.4 | GO:0004886 | 9-cis retinoic acid receptor activity(GO:0004886) |
0.7 | 20.2 | GO:0001540 | beta-amyloid binding(GO:0001540) |
0.6 | 3.2 | GO:0044323 | retinoic acid-responsive element binding(GO:0044323) |
0.6 | 1.8 | GO:0005519 | cytoskeletal regulatory protein binding(GO:0005519) |
0.6 | 3.0 | GO:0086006 | voltage-gated sodium channel activity involved in cardiac muscle cell action potential(GO:0086006) |
0.6 | 2.8 | GO:0004826 | phenylalanine-tRNA ligase activity(GO:0004826) |
0.6 | 1.1 | GO:0097016 | L27 domain binding(GO:0097016) |
0.5 | 6.4 | GO:0015643 | toxic substance binding(GO:0015643) |
0.5 | 2.0 | GO:0005042 | netrin receptor activity(GO:0005042) |
0.5 | 6.4 | GO:0005092 | GDP-dissociation inhibitor activity(GO:0005092) |
0.5 | 1.9 | GO:0052833 | inositol monophosphate 1-phosphatase activity(GO:0008934) inositol monophosphate 3-phosphatase activity(GO:0052832) inositol monophosphate 4-phosphatase activity(GO:0052833) inositol monophosphate phosphatase activity(GO:0052834) |
0.4 | 1.8 | GO:0033142 | progesterone receptor binding(GO:0033142) |
0.4 | 3.0 | GO:0004908 | interleukin-1 receptor activity(GO:0004908) |
0.4 | 7.7 | GO:0051428 | peptide hormone receptor binding(GO:0051428) |
0.4 | 2.1 | GO:0004111 | creatine kinase activity(GO:0004111) |
0.4 | 1.2 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
0.4 | 2.8 | GO:0008020 | G-protein coupled photoreceptor activity(GO:0008020) |
0.4 | 1.2 | GO:0097108 | hedgehog family protein binding(GO:0097108) |
0.4 | 1.1 | GO:0005483 | soluble NSF attachment protein activity(GO:0005483) |
0.4 | 0.8 | GO:0015142 | citrate transmembrane transporter activity(GO:0015137) tricarboxylic acid transmembrane transporter activity(GO:0015142) |
0.4 | 1.5 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
0.4 | 1.9 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
0.4 | 2.2 | GO:0035242 | protein-arginine omega-N asymmetric methyltransferase activity(GO:0035242) |
0.4 | 3.2 | GO:0001091 | RNA polymerase II basal transcription factor binding(GO:0001091) |
0.4 | 0.7 | GO:0043423 | 3-phosphoinositide-dependent protein kinase binding(GO:0043423) |
0.4 | 5.3 | GO:0016805 | dipeptidase activity(GO:0016805) |
0.4 | 0.7 | GO:0005001 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) |
0.3 | 1.0 | GO:0045503 | dynein light chain binding(GO:0045503) |
0.3 | 1.0 | GO:0004103 | choline kinase activity(GO:0004103) |
0.3 | 1.0 | GO:0003708 | retinoic acid receptor activity(GO:0003708) |
0.3 | 23.3 | GO:0035250 | UDP-galactosyltransferase activity(GO:0035250) |
0.3 | 2.8 | GO:0016920 | pyroglutamyl-peptidase activity(GO:0016920) |
0.3 | 1.5 | GO:0015277 | kainate selective glutamate receptor activity(GO:0015277) |
0.3 | 0.6 | GO:0015222 | serotonin transmembrane transporter activity(GO:0015222) |
0.3 | 0.9 | GO:0034513 | box H/ACA snoRNA binding(GO:0034513) |
0.3 | 0.6 | GO:0038064 | collagen receptor activity(GO:0038064) |
0.3 | 7.6 | GO:0001106 | RNA polymerase II transcription corepressor activity(GO:0001106) |
0.3 | 1.2 | GO:0031694 | alpha-2A adrenergic receptor binding(GO:0031694) |
0.3 | 2.1 | GO:0004716 | receptor signaling protein tyrosine kinase activity(GO:0004716) |
0.3 | 1.5 | GO:0034190 | apolipoprotein receptor binding(GO:0034190) |
0.3 | 1.5 | GO:0004957 | prostaglandin E receptor activity(GO:0004957) |
0.3 | 0.8 | GO:0035663 | Toll-like receptor 2 binding(GO:0035663) |
0.3 | 1.1 | GO:0016833 | oxo-acid-lyase activity(GO:0016833) |
0.3 | 1.1 | GO:0005250 | A-type (transient outward) potassium channel activity(GO:0005250) |
0.3 | 1.1 | GO:0004045 | aminoacyl-tRNA hydrolase activity(GO:0004045) |
0.3 | 2.4 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
0.3 | 1.1 | GO:0003846 | 2-acylglycerol O-acyltransferase activity(GO:0003846) |
0.3 | 1.6 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
0.3 | 0.5 | GO:0031711 | bradykinin receptor binding(GO:0031711) |
0.3 | 1.0 | GO:0043842 | Kdo transferase activity(GO:0043842) |
0.3 | 0.8 | GO:0008310 | single-stranded DNA 3'-5' exodeoxyribonuclease activity(GO:0008310) |
0.3 | 1.0 | GO:0005275 | amine transmembrane transporter activity(GO:0005275) |
0.3 | 0.8 | GO:0050816 | phosphothreonine binding(GO:0050816) |
0.3 | 0.8 | GO:0015271 | outward rectifier potassium channel activity(GO:0015271) |
0.2 | 0.7 | GO:0004829 | threonine-tRNA ligase activity(GO:0004829) |
0.2 | 1.2 | GO:0008294 | calcium- and calmodulin-responsive adenylate cyclase activity(GO:0008294) |
0.2 | 1.7 | GO:0003680 | AT DNA binding(GO:0003680) |
0.2 | 1.0 | GO:0004370 | glycerol kinase activity(GO:0004370) |
0.2 | 16.2 | GO:0048306 | calcium-dependent protein binding(GO:0048306) |
0.2 | 3.4 | GO:0005351 | sugar:proton symporter activity(GO:0005351) |
0.2 | 1.0 | GO:1901611 | phosphatidylglycerol binding(GO:1901611) |
0.2 | 3.1 | GO:0004970 | ionotropic glutamate receptor activity(GO:0004970) |
0.2 | 3.1 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
0.2 | 1.2 | GO:0004758 | serine C-palmitoyltransferase activity(GO:0004758) |
0.2 | 3.1 | GO:0070742 | C2H2 zinc finger domain binding(GO:0070742) |
0.2 | 2.6 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
0.2 | 1.2 | GO:0098639 | collagen binding involved in cell-matrix adhesion(GO:0098639) |
0.2 | 0.9 | GO:0004614 | phosphoglucomutase activity(GO:0004614) |
0.2 | 1.4 | GO:0015198 | oligopeptide transporter activity(GO:0015198) |
0.2 | 0.7 | GO:0032137 | guanine/thymine mispair binding(GO:0032137) |
0.2 | 0.9 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
0.2 | 2.6 | GO:0016500 | protein-hormone receptor activity(GO:0016500) |
0.2 | 1.1 | GO:0005324 | long-chain fatty acid transporter activity(GO:0005324) |
0.2 | 0.7 | GO:0003987 | acetate-CoA ligase activity(GO:0003987) |
0.2 | 3.2 | GO:0030553 | cGMP binding(GO:0030553) |
0.2 | 1.9 | GO:0005313 | L-glutamate transmembrane transporter activity(GO:0005313) |
0.2 | 0.4 | GO:0030519 | snoRNP binding(GO:0030519) |
0.2 | 1.5 | GO:0031628 | opioid receptor binding(GO:0031628) |
0.2 | 0.6 | GO:0016743 | carboxyl- or carbamoyltransferase activity(GO:0016743) |
0.2 | 0.8 | GO:0046974 | histone methyltransferase activity (H3-K9 specific)(GO:0046974) |
0.2 | 0.4 | GO:0034988 | Fc-gamma receptor I complex binding(GO:0034988) |
0.2 | 0.4 | GO:0031697 | beta-1 adrenergic receptor binding(GO:0031697) |
0.2 | 1.0 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
0.2 | 2.6 | GO:0005487 | nucleocytoplasmic transporter activity(GO:0005487) |
0.2 | 1.2 | GO:0048495 | Roundabout binding(GO:0048495) |
0.2 | 4.1 | GO:0004707 | MAP kinase activity(GO:0004707) |
0.2 | 0.6 | GO:0016647 | oxidoreductase activity, acting on the CH-NH group of donors, oxygen as acceptor(GO:0016647) |
0.2 | 1.5 | GO:0023026 | MHC class II protein complex binding(GO:0023026) |
0.2 | 1.7 | GO:0018855 | 3-oxo-2-(2'-pentenyl)cyclopentane-1-octanoic acid CoA ligase activity(GO:0010435) 3-isopropenyl-6-oxoheptanoyl-CoA synthetase activity(GO:0018854) 2-oxo-delta3-4,5,5-trimethylcyclopentenylacetyl-CoA synthetase activity(GO:0018855) benzoyl acetate-CoA ligase activity(GO:0018856) 2,4-dichlorobenzoate-CoA ligase activity(GO:0018857) pivalate-CoA ligase activity(GO:0034783) cyclopropanecarboxylate-CoA ligase activity(GO:0034793) adipate-CoA ligase activity(GO:0034796) citronellyl-CoA ligase activity(GO:0034823) mentha-1,3-dione-CoA ligase activity(GO:0034841) thiophene-2-carboxylate-CoA ligase activity(GO:0034842) 2,4,4-trimethylpentanoate-CoA ligase activity(GO:0034865) cis-2-methyl-5-isopropylhexa-2,5-dienoate-CoA ligase activity(GO:0034942) trans-2-methyl-5-isopropylhexa-2,5-dienoate-CoA ligase activity(GO:0034943) branched-chain acyl-CoA synthetase (ADP-forming) activity(GO:0043759) aryl-CoA synthetase (ADP-forming) activity(GO:0043762) 3-hydroxypropionyl-CoA synthetase activity(GO:0043955) perillic acid:CoA ligase (ADP-forming) activity(GO:0052685) perillic acid:CoA ligase (AMP-forming) activity(GO:0052686) (3R)-3-isopropenyl-6-oxoheptanoate:CoA ligase (ADP-forming) activity(GO:0052687) (3R)-3-isopropenyl-6-oxoheptanoate:CoA ligase (AMP-forming) activity(GO:0052688) pristanate-CoA ligase activity(GO:0070251) malonyl-CoA synthetase activity(GO:0090409) |
0.2 | 0.6 | GO:0061629 | RNA polymerase II sequence-specific DNA binding transcription factor binding(GO:0061629) |
0.2 | 0.4 | GO:0032357 | oxidized DNA binding(GO:0032356) oxidized purine DNA binding(GO:0032357) |
0.2 | 0.7 | GO:0070883 | pre-miRNA binding(GO:0070883) |
0.2 | 0.6 | GO:0030297 | transmembrane receptor protein tyrosine kinase activator activity(GO:0030297) |
0.2 | 0.9 | GO:0070290 | N-acylphosphatidylethanolamine-specific phospholipase D activity(GO:0070290) |
0.2 | 5.7 | GO:0042169 | SH2 domain binding(GO:0042169) |
0.2 | 1.1 | GO:0046790 | virion binding(GO:0046790) |
0.2 | 0.5 | GO:0032190 | acrosin binding(GO:0032190) |
0.2 | 0.7 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
0.2 | 0.4 | GO:0046870 | cadmium ion binding(GO:0046870) |
0.2 | 2.8 | GO:0035255 | ionotropic glutamate receptor binding(GO:0035255) |
0.2 | 2.1 | GO:0004000 | adenosine deaminase activity(GO:0004000) |
0.2 | 0.7 | GO:0009374 | biotin binding(GO:0009374) |
0.2 | 0.3 | GO:0001642 | group III metabotropic glutamate receptor activity(GO:0001642) |
0.2 | 1.0 | GO:0008517 | folic acid transporter activity(GO:0008517) |
0.2 | 5.4 | GO:0005251 | delayed rectifier potassium channel activity(GO:0005251) |
0.2 | 2.4 | GO:0001671 | ATPase activator activity(GO:0001671) |
0.2 | 0.5 | GO:0000403 | Y-form DNA binding(GO:0000403) |
0.2 | 0.7 | GO:0005030 | neurotrophin receptor activity(GO:0005030) |
0.2 | 0.5 | GO:0030350 | iron-responsive element binding(GO:0030350) |
0.2 | 0.6 | GO:0015349 | thyroid hormone transmembrane transporter activity(GO:0015349) |
0.2 | 0.6 | GO:0052851 | cupric reductase activity(GO:0008823) ferric-chelate reductase (NADPH) activity(GO:0052851) |
0.2 | 0.5 | GO:0004942 | anaphylatoxin receptor activity(GO:0004942) |
0.2 | 0.8 | GO:0016721 | superoxide dismutase activity(GO:0004784) oxidoreductase activity, acting on superoxide radicals as acceptor(GO:0016721) |
0.2 | 0.8 | GO:0005072 | transforming growth factor beta receptor, cytoplasmic mediator activity(GO:0005072) |
0.2 | 2.3 | GO:0016661 | oxidoreductase activity, acting on other nitrogenous compounds as donors(GO:0016661) |
0.2 | 0.3 | GO:0015173 | aromatic amino acid transmembrane transporter activity(GO:0015173) |
0.2 | 0.5 | GO:0035175 | histone kinase activity (H3-S10 specific)(GO:0035175) |
0.2 | 1.1 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
0.1 | 0.3 | GO:0060228 | phosphatidylcholine-sterol O-acyltransferase activator activity(GO:0060228) |
0.1 | 4.2 | GO:0017080 | sodium channel regulator activity(GO:0017080) |
0.1 | 1.5 | GO:0070636 | single-strand selective uracil DNA N-glycosylase activity(GO:0017065) nicotinamide riboside hydrolase activity(GO:0070635) nicotinic acid riboside hydrolase activity(GO:0070636) deoxyribonucleoside 5'-monophosphate N-glycosidase activity(GO:0070694) |
0.1 | 0.4 | GO:0004365 | glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity(GO:0004365) glyceraldehyde-3-phosphate dehydrogenase (NAD(P)+) (phosphorylating) activity(GO:0043891) |
0.1 | 1.1 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
0.1 | 0.4 | GO:1990190 | peptide-serine-N-acetyltransferase activity(GO:1990189) peptide-glutamate-N-acetyltransferase activity(GO:1990190) |
0.1 | 0.4 | GO:0009881 | photoreceptor activity(GO:0009881) |
0.1 | 0.8 | GO:0008479 | queuine tRNA-ribosyltransferase activity(GO:0008479) |
0.1 | 1.5 | GO:0001161 | intronic transcription regulatory region sequence-specific DNA binding(GO:0001161) |
0.1 | 0.7 | GO:0004985 | opioid receptor activity(GO:0004985) |
0.1 | 3.3 | GO:0015459 | potassium channel regulator activity(GO:0015459) |
0.1 | 0.8 | GO:0019992 | diacylglycerol binding(GO:0019992) |
0.1 | 0.5 | GO:0005280 | hydrogen:amino acid symporter activity(GO:0005280) |
0.1 | 1.3 | GO:0004568 | chitinase activity(GO:0004568) |
0.1 | 0.4 | GO:0042030 | ATPase inhibitor activity(GO:0042030) |
0.1 | 6.6 | GO:0017022 | myosin binding(GO:0017022) |
0.1 | 0.4 | GO:0050833 | pyruvate transmembrane transporter activity(GO:0050833) |
0.1 | 1.6 | GO:0015269 | calcium-activated potassium channel activity(GO:0015269) |
0.1 | 0.5 | GO:0016212 | kynurenine-oxoglutarate transaminase activity(GO:0016212) kynurenine aminotransferase activity(GO:0036137) |
0.1 | 1.0 | GO:0008889 | glycerophosphodiester phosphodiesterase activity(GO:0008889) |
0.1 | 0.8 | GO:0032454 | histone demethylase activity (H3-K9 specific)(GO:0032454) |
0.1 | 0.7 | GO:0033691 | sialic acid binding(GO:0033691) |
0.1 | 0.5 | GO:0070815 | peptidyl-lysine 5-dioxygenase activity(GO:0070815) |
0.1 | 0.9 | GO:0043008 | ATP-dependent protein binding(GO:0043008) |
0.1 | 0.1 | GO:0005223 | intracellular cGMP activated cation channel activity(GO:0005223) |
0.1 | 0.4 | GO:0036042 | long-chain fatty acyl-CoA binding(GO:0036042) |
0.1 | 0.6 | GO:0086080 | protein binding involved in heterotypic cell-cell adhesion(GO:0086080) |
0.1 | 0.2 | GO:0030158 | protein xylosyltransferase activity(GO:0030158) |
0.1 | 3.2 | GO:0043425 | bHLH transcription factor binding(GO:0043425) |
0.1 | 0.8 | GO:0003836 | beta-galactoside (CMP) alpha-2,3-sialyltransferase activity(GO:0003836) |
0.1 | 0.5 | GO:0004969 | histamine receptor activity(GO:0004969) |
0.1 | 0.3 | GO:0009041 | uridylate kinase activity(GO:0009041) |
0.1 | 0.2 | GO:0042392 | sphingosine-1-phosphate phosphatase activity(GO:0042392) |
0.1 | 0.3 | GO:0008184 | glycogen phosphorylase activity(GO:0008184) |
0.1 | 0.3 | GO:0015111 | iodide transmembrane transporter activity(GO:0015111) |
0.1 | 0.2 | GO:0048763 | calcium-induced calcium release activity(GO:0048763) |
0.1 | 0.3 | GO:0019862 | IgA binding(GO:0019862) |
0.1 | 0.5 | GO:0003906 | DNA-(apurinic or apyrimidinic site) lyase activity(GO:0003906) |
0.1 | 1.0 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
0.1 | 0.4 | GO:0015375 | glycine:sodium symporter activity(GO:0015375) |
0.1 | 0.3 | GO:0043546 | molybdopterin cofactor binding(GO:0043546) |
0.1 | 0.6 | GO:0030159 | receptor signaling complex scaffold activity(GO:0030159) |
0.1 | 0.3 | GO:0008147 | structural constituent of bone(GO:0008147) |
0.1 | 0.7 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
0.1 | 0.4 | GO:0034056 | estrogen response element binding(GO:0034056) |
0.1 | 4.0 | GO:0098811 | transcriptional activator activity, RNA polymerase II transcription factor binding(GO:0001190) transcriptional repressor activity, RNA polymerase II activating transcription factor binding(GO:0098811) |
0.1 | 2.4 | GO:0001205 | transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001205) |
0.1 | 0.1 | GO:0070653 | high-density lipoprotein particle receptor binding(GO:0070653) |
0.1 | 0.3 | GO:0008900 | hydrogen:potassium-exchanging ATPase activity(GO:0008900) |
0.1 | 0.3 | GO:0071558 | histone demethylase activity (H3-K27 specific)(GO:0071558) |
0.1 | 0.7 | GO:0005375 | copper ion transmembrane transporter activity(GO:0005375) |
0.1 | 0.5 | GO:0004523 | RNA-DNA hybrid ribonuclease activity(GO:0004523) |
0.1 | 0.5 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
0.1 | 1.3 | GO:0099589 | G-protein coupled serotonin receptor activity(GO:0004993) serotonin receptor activity(GO:0099589) |
0.1 | 0.2 | GO:0031698 | beta-2 adrenergic receptor binding(GO:0031698) |
0.1 | 0.3 | GO:0042296 | ISG15 transferase activity(GO:0042296) |
0.1 | 0.3 | GO:0016015 | morphogen activity(GO:0016015) |
0.1 | 0.8 | GO:0015385 | sodium:proton antiporter activity(GO:0015385) potassium:proton antiporter activity(GO:0015386) |
0.1 | 0.3 | GO:0016508 | long-chain-enoyl-CoA hydratase activity(GO:0016508) |
0.1 | 0.1 | GO:0035851 | Krueppel-associated box domain binding(GO:0035851) |
0.1 | 0.2 | GO:0031014 | troponin T binding(GO:0031014) |
0.1 | 1.0 | GO:0034237 | protein kinase A regulatory subunit binding(GO:0034237) |
0.1 | 2.0 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
0.1 | 0.3 | GO:0016635 | oxidoreductase activity, acting on the CH-CH group of donors, quinone or related compound as acceptor(GO:0016635) |
0.1 | 0.4 | GO:0004791 | thioredoxin-disulfide reductase activity(GO:0004791) |
0.1 | 1.5 | GO:0080025 | phosphatidylinositol-3,5-bisphosphate binding(GO:0080025) |
0.1 | 0.9 | GO:0005522 | profilin binding(GO:0005522) |
0.1 | 0.2 | GO:0004897 | ciliary neurotrophic factor receptor activity(GO:0004897) |
0.1 | 1.5 | GO:0005528 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
0.1 | 0.5 | GO:0047184 | 1-acylglycerophosphocholine O-acyltransferase activity(GO:0047184) |
0.1 | 3.5 | GO:0008907 | integrase activity(GO:0008907) T/G mismatch-specific endonuclease activity(GO:0043765) retroviral integrase activity(GO:0044823) retroviral 3' processing activity(GO:0044824) |
0.1 | 0.6 | GO:0043023 | ribosomal large subunit binding(GO:0043023) |
0.1 | 1.1 | GO:0005248 | voltage-gated sodium channel activity(GO:0005248) voltage-gated ion channel activity involved in regulation of postsynaptic membrane potential(GO:1905030) |
0.1 | 0.1 | GO:0035939 | microsatellite binding(GO:0035939) |
0.1 | 0.2 | GO:0047045 | testosterone 17-beta-dehydrogenase (NADP+) activity(GO:0047045) |
0.1 | 0.3 | GO:0015220 | choline transmembrane transporter activity(GO:0015220) |
0.1 | 0.2 | GO:0019237 | centromeric DNA binding(GO:0019237) |
0.1 | 0.5 | GO:0031681 | G-protein beta-subunit binding(GO:0031681) |
0.1 | 0.1 | GO:0031433 | telethonin binding(GO:0031433) |
0.1 | 0.3 | GO:0032052 | bile acid binding(GO:0032052) |
0.1 | 0.2 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
0.1 | 0.3 | GO:0001602 | pancreatic polypeptide receptor activity(GO:0001602) |
0.1 | 0.8 | GO:0016929 | SUMO-specific protease activity(GO:0016929) |
0.1 | 0.2 | GO:0043888 | 4-hydroxybenzoate octaprenyltransferase activity(GO:0008412) protoheme IX farnesyltransferase activity(GO:0008495) (S)-2,3-di-O-geranylgeranylglyceryl phosphate synthase activity(GO:0043888) cadaverine aminopropyltransferase activity(GO:0043918) agmatine aminopropyltransferase activity(GO:0043919) 1,4-dihydroxy-2-naphthoate octaprenyltransferase activity(GO:0046428) trans-pentaprenyltranstransferase activity(GO:0048045) ATP dimethylallyltransferase activity(GO:0052622) ADP dimethylallyltransferase activity(GO:0052623) |
0.1 | 0.1 | GO:0008545 | JUN kinase kinase activity(GO:0008545) |
0.1 | 0.3 | GO:0032051 | clathrin light chain binding(GO:0032051) |
0.1 | 0.1 | GO:0016520 | growth hormone-releasing hormone receptor activity(GO:0016520) |
0.1 | 0.2 | GO:0031735 | CCR10 chemokine receptor binding(GO:0031735) |
0.1 | 0.7 | GO:0008195 | phosphatidate phosphatase activity(GO:0008195) |
0.1 | 1.4 | GO:0001102 | RNA polymerase II activating transcription factor binding(GO:0001102) |
0.1 | 0.2 | GO:0019976 | interleukin-2 binding(GO:0019976) |
0.1 | 0.1 | GO:0016933 | extracellular-glycine-gated ion channel activity(GO:0016933) extracellular-glycine-gated chloride channel activity(GO:0016934) |
0.1 | 0.3 | GO:0016901 | oxidoreductase activity, acting on the CH-OH group of donors, quinone or similar compound as acceptor(GO:0016901) |
0.1 | 3.5 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
0.1 | 0.2 | GO:0030943 | mitochondrion targeting sequence binding(GO:0030943) |
0.1 | 6.0 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.1 | 0.2 | GO:0004470 | malic enzyme activity(GO:0004470) malate dehydrogenase (decarboxylating) (NAD+) activity(GO:0004471) |
0.1 | 1.1 | GO:0005452 | inorganic anion exchanger activity(GO:0005452) |
0.1 | 0.1 | GO:0000099 | sulfur amino acid transmembrane transporter activity(GO:0000099) |
0.1 | 0.2 | GO:0038100 | nodal binding(GO:0038100) |
0.1 | 0.2 | GO:0047756 | chondroitin 4-sulfotransferase activity(GO:0047756) |
0.1 | 0.1 | GO:0003996 | acyl-CoA ligase activity(GO:0003996) |
0.1 | 0.3 | GO:0004708 | MAP kinase kinase activity(GO:0004708) |
0.1 | 0.5 | GO:0034871 | pinocarveol dehydrogenase activity(GO:0018446) chloral hydrate dehydrogenase activity(GO:0018447) hydroxymethylmethylsilanediol oxidase activity(GO:0018448) 1-phenylethanol dehydrogenase activity(GO:0018449) myrtenol dehydrogenase activity(GO:0018450) cis-1,2-dihydroxy-1,2-dihydro-8-carboxynaphthalene dehydrogenase activity(GO:0034522) 3-hydroxy-4-methyloctanoyl-CoA dehydrogenase activity(GO:0034582) 2-hydroxy-4-isopropenylcyclohexane-1-carboxyl-CoA dehydrogenase activity(GO:0034778) cis-9,10-dihydroanthracene-9,10-diol dehydrogenase activity(GO:0034817) citronellol dehydrogenase activity(GO:0034821) naphthyl-2-hydroxymethyl-succinyl-CoA dehydrogenase activity(GO:0034847) 2,4,4-trimethyl-1-pentanol dehydrogenase activity(GO:0034863) 2,4,4-trimethyl-3-hydroxypentanoyl-CoA dehydrogenase activity(GO:0034868) 1-hydroxy-4,4-dimethylpentan-3-one dehydrogenase activity(GO:0034871) endosulfan diol dehydrogenase activity(GO:0034891) endosulfan hydroxyether dehydrogenase activity(GO:0034901) 3-hydroxy-2-methylhexanoyl-CoA dehydrogenase activity(GO:0034918) 3-hydroxy-2,6-dimethyl-5-methylene-heptanoyl-CoA dehydrogenase activity(GO:0034944) versicolorin reductase activity(GO:0042469) ketoreductase activity(GO:0045703) |
0.1 | 0.3 | GO:0004994 | somatostatin receptor activity(GO:0004994) |
0.1 | 0.3 | GO:0004322 | ferroxidase activity(GO:0004322) oxidoreductase activity, oxidizing metal ions, oxygen as acceptor(GO:0016724) |
0.1 | 0.2 | GO:0019153 | protein-disulfide reductase (glutathione) activity(GO:0019153) |
0.1 | 1.2 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
0.1 | 0.4 | GO:0031386 | protein tag(GO:0031386) |
0.1 | 0.2 | GO:0019776 | Atg8 ligase activity(GO:0019776) |
0.1 | 0.2 | GO:0016151 | nickel cation binding(GO:0016151) |
0.1 | 0.2 | GO:0097603 | temperature-gated ion channel activity(GO:0097603) |
0.1 | 0.2 | GO:0005004 | GPI-linked ephrin receptor activity(GO:0005004) |
0.0 | 0.3 | GO:0048027 | mRNA 5'-UTR binding(GO:0048027) |
0.0 | 0.1 | GO:0004980 | melanocyte-stimulating hormone receptor activity(GO:0004980) |
0.0 | 0.2 | GO:0004596 | peptide alpha-N-acetyltransferase activity(GO:0004596) |
0.0 | 0.3 | GO:0031419 | cobalamin binding(GO:0031419) |
0.0 | 0.8 | GO:0019239 | deaminase activity(GO:0019239) |
0.0 | 0.1 | GO:0034648 | histone demethylase activity (H3-dimethyl-K4 specific)(GO:0034648) |
0.0 | 0.1 | GO:0030346 | protein phosphatase 2B binding(GO:0030346) |
0.0 | 0.2 | GO:0017176 | phosphatidylinositol N-acetylglucosaminyltransferase activity(GO:0017176) |
0.0 | 0.2 | GO:0036033 | mediator complex binding(GO:0036033) |
0.0 | 0.5 | GO:0016713 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced iron-sulfur protein as one donor, and incorporation of one atom of oxygen(GO:0016713) |
0.0 | 0.2 | GO:0016899 | oxidoreductase activity, acting on the CH-OH group of donors, oxygen as acceptor(GO:0016899) |
0.0 | 0.1 | GO:0003872 | 6-phosphofructokinase activity(GO:0003872) |
0.0 | 0.1 | GO:0070905 | serine binding(GO:0070905) |
0.0 | 0.1 | GO:0003941 | L-serine ammonia-lyase activity(GO:0003941) |
0.0 | 0.2 | GO:0055131 | C3HC4-type RING finger domain binding(GO:0055131) |
0.0 | 1.0 | GO:0052629 | phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity(GO:0052629) |
0.0 | 0.1 | GO:0015199 | amino-acid betaine transmembrane transporter activity(GO:0015199) carnitine transmembrane transporter activity(GO:0015226) |
0.0 | 0.3 | GO:0032050 | clathrin heavy chain binding(GO:0032050) |
0.0 | 0.1 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
0.0 | 0.1 | GO:0004937 | alpha1-adrenergic receptor activity(GO:0004937) |
0.0 | 0.8 | GO:0051018 | protein kinase A binding(GO:0051018) |
0.0 | 0.0 | GO:0004731 | purine-nucleoside phosphorylase activity(GO:0004731) |
0.0 | 0.3 | GO:0022835 | transmitter-gated ion channel activity(GO:0022824) transmitter-gated channel activity(GO:0022835) |
0.0 | 0.1 | GO:0097493 | structural molecule activity conferring elasticity(GO:0097493) |
0.0 | 0.1 | GO:0016822 | hydrolase activity, acting on acid carbon-carbon bonds(GO:0016822) hydrolase activity, acting on acid carbon-carbon bonds, in ketonic substances(GO:0016823) |
0.0 | 0.2 | GO:0047760 | butyrate-CoA ligase activity(GO:0047760) |
0.0 | 0.1 | GO:0005105 | type 1 fibroblast growth factor receptor binding(GO:0005105) |
0.0 | 0.2 | GO:0002054 | nucleobase binding(GO:0002054) |
0.0 | 1.1 | GO:0005132 | type I interferon receptor binding(GO:0005132) |
0.0 | 1.5 | GO:0008392 | arachidonic acid epoxygenase activity(GO:0008392) |
0.0 | 0.0 | GO:0016530 | metallochaperone activity(GO:0016530) |
0.0 | 0.5 | GO:0005229 | intracellular calcium activated chloride channel activity(GO:0005229) |
0.0 | 0.1 | GO:1990050 | phosphatidic acid transporter activity(GO:1990050) |
0.0 | 0.2 | GO:0016681 | ubiquinol-cytochrome-c reductase activity(GO:0008121) oxidoreductase activity, acting on diphenols and related substances as donors, cytochrome as acceptor(GO:0016681) |
0.0 | 0.8 | GO:0045499 | chemorepellent activity(GO:0045499) |
0.0 | 0.6 | GO:0016917 | GABA receptor activity(GO:0016917) |
0.0 | 0.1 | GO:0005134 | interleukin-2 receptor binding(GO:0005134) |
0.0 | 0.2 | GO:0004983 | neuropeptide Y receptor activity(GO:0004983) |
0.0 | 0.2 | GO:0015379 | potassium:chloride symporter activity(GO:0015379) potassium ion symporter activity(GO:0022820) |
0.0 | 0.1 | GO:0005415 | nucleoside:sodium symporter activity(GO:0005415) |
0.0 | 0.3 | GO:0015347 | sodium-independent organic anion transmembrane transporter activity(GO:0015347) |
0.0 | 0.1 | GO:0030619 | U1 snRNA binding(GO:0030619) |
0.0 | 0.1 | GO:0004946 | bombesin receptor activity(GO:0004946) |
0.0 | 0.9 | GO:0031624 | ubiquitin conjugating enzyme binding(GO:0031624) |
0.0 | 0.2 | GO:0004303 | estradiol 17-beta-dehydrogenase activity(GO:0004303) |
0.0 | 0.1 | GO:0036402 | proteasome-activating ATPase activity(GO:0036402) |
0.0 | 0.1 | GO:0004075 | biotin carboxylase activity(GO:0004075) |
0.0 | 0.2 | GO:0005003 | ephrin receptor activity(GO:0005003) |
0.0 | 0.1 | GO:0070052 | collagen V binding(GO:0070052) |
0.0 | 0.1 | GO:0005006 | epidermal growth factor-activated receptor activity(GO:0005006) |
0.0 | 0.2 | GO:0004579 | dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
0.0 | 0.1 | GO:0019966 | interleukin-1 binding(GO:0019966) |
0.0 | 0.1 | GO:0019797 | procollagen-proline 3-dioxygenase activity(GO:0019797) |
0.0 | 0.1 | GO:0015193 | L-proline transmembrane transporter activity(GO:0015193) |
0.0 | 1.6 | GO:0008186 | ATP-dependent RNA helicase activity(GO:0004004) RNA-dependent ATPase activity(GO:0008186) |
0.0 | 0.1 | GO:0031493 | nucleosomal histone binding(GO:0031493) |
0.0 | 0.1 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
0.0 | 0.1 | GO:0051373 | FATZ binding(GO:0051373) |
0.0 | 0.1 | GO:0070326 | very-low-density lipoprotein particle receptor binding(GO:0070326) |
0.0 | 1.5 | GO:0051082 | unfolded protein binding(GO:0051082) |
0.0 | 0.0 | GO:0017098 | sulfonylurea receptor binding(GO:0017098) |
0.0 | 0.2 | GO:0003688 | DNA replication origin binding(GO:0003688) |
0.0 | 0.2 | GO:0005388 | calcium-transporting ATPase activity(GO:0005388) |
0.0 | 0.2 | GO:0008242 | omega peptidase activity(GO:0008242) |
0.0 | 0.1 | GO:0047498 | calcium-dependent phospholipase A2 activity(GO:0047498) |
0.0 | 0.1 | GO:0004667 | prostaglandin-D synthase activity(GO:0004667) |
0.0 | 0.1 | GO:2001069 | glycogen binding(GO:2001069) |
0.0 | 0.0 | GO:0004096 | catalase activity(GO:0004096) |
0.0 | 0.8 | GO:0042054 | histone methyltransferase activity(GO:0042054) |
0.0 | 0.2 | GO:0070182 | DNA polymerase binding(GO:0070182) |
0.0 | 0.1 | GO:0015252 | hydrogen ion channel activity(GO:0015252) |
0.0 | 0.2 | GO:0008373 | sialyltransferase activity(GO:0008373) |
0.0 | 0.1 | GO:0005113 | patched binding(GO:0005113) |
0.0 | 0.0 | GO:0016972 | thiol oxidase activity(GO:0016972) |
0.0 | 0.7 | GO:0005544 | calcium-dependent phospholipid binding(GO:0005544) |
0.0 | 0.1 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
0.0 | 0.1 | GO:0048019 | receptor antagonist activity(GO:0048019) |
0.0 | 0.1 | GO:0004514 | nicotinate-nucleotide diphosphorylase (carboxylating) activity(GO:0004514) |
0.0 | 1.8 | GO:0016810 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds(GO:0016810) |
0.0 | 0.1 | GO:0005047 | signal recognition particle binding(GO:0005047) |
0.0 | 0.7 | GO:0043022 | ribosome binding(GO:0043022) |
0.0 | 0.4 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
0.0 | 0.1 | GO:0004699 | calcium-independent protein kinase C activity(GO:0004699) |
0.0 | 0.1 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
0.0 | 0.1 | GO:0042284 | sphingolipid delta-4 desaturase activity(GO:0042284) |
0.0 | 0.3 | GO:0004435 | phosphatidylinositol phospholipase C activity(GO:0004435) |
0.0 | 0.1 | GO:0005166 | neurotrophin p75 receptor binding(GO:0005166) |
0.0 | 0.0 | GO:0048408 | epidermal growth factor binding(GO:0048408) |
0.0 | 0.1 | GO:0047499 | calcium-independent phospholipase A2 activity(GO:0047499) |
0.0 | 0.0 | GO:0008503 | benzodiazepine receptor activity(GO:0008503) |
0.0 | 0.2 | GO:0043138 | 3'-5' DNA helicase activity(GO:0043138) |
0.0 | 0.0 | GO:0000386 | second spliceosomal transesterification activity(GO:0000386) |
0.0 | 0.3 | GO:0051990 | (R)-2-hydroxyglutarate dehydrogenase activity(GO:0051990) |
0.0 | 0.0 | GO:0038085 | vascular endothelial growth factor binding(GO:0038085) |
0.0 | 0.0 | GO:0051765 | inositol tetrakisphosphate kinase activity(GO:0051765) |
0.0 | 0.2 | GO:0005149 | interleukin-1 receptor binding(GO:0005149) |
0.0 | 0.1 | GO:0005143 | interleukin-12 receptor binding(GO:0005143) |
0.0 | 0.0 | GO:0008384 | IkappaB kinase activity(GO:0008384) |
0.0 | 0.1 | GO:0008440 | inositol-1,4,5-trisphosphate 3-kinase activity(GO:0008440) |
0.0 | 0.0 | GO:0070538 | oleic acid binding(GO:0070538) |
0.0 | 0.0 | GO:0050567 | glutaminyl-tRNA synthase (glutamine-hydrolyzing) activity(GO:0050567) |
0.0 | 0.0 | GO:0008035 | high-density lipoprotein particle binding(GO:0008035) |
0.0 | 0.0 | GO:0047023 | androsterone dehydrogenase activity(GO:0047023) |
0.0 | 0.0 | GO:0030621 | U4 snRNA binding(GO:0030621) |
0.0 | 0.0 | GO:0001875 | lipopolysaccharide receptor activity(GO:0001875) |
0.0 | 0.1 | GO:0001618 | virus receptor activity(GO:0001618) |
0.0 | 0.0 | GO:0052658 | inositol-1,4,5-trisphosphate 5-phosphatase activity(GO:0052658) |
0.0 | 0.0 | GO:0005148 | prolactin receptor binding(GO:0005148) |
0.0 | 0.1 | GO:0034185 | apolipoprotein binding(GO:0034185) |
0.0 | 0.1 | GO:0004499 | N,N-dimethylaniline monooxygenase activity(GO:0004499) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.7 | 10.7 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.3 | 3.8 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
0.2 | 3.6 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.2 | 0.4 | PID INTEGRIN1 PATHWAY | Beta1 integrin cell surface interactions |
0.2 | 9.2 | ST T CELL SIGNAL TRANSDUCTION | T Cell Signal Transduction |
0.2 | 4.3 | PID REELIN PATHWAY | Reelin signaling pathway |
0.2 | 3.7 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
0.2 | 0.5 | ST PHOSPHOINOSITIDE 3 KINASE PATHWAY | PI3K Pathway |
0.1 | 0.9 | PID IFNG PATHWAY | IFN-gamma pathway |
0.1 | 3.0 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.1 | 1.0 | ST GA12 PATHWAY | G alpha 12 Pathway |
0.1 | 1.2 | PID FGF PATHWAY | FGF signaling pathway |
0.1 | 3.3 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
0.1 | 0.5 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
0.1 | 1.0 | ST B CELL ANTIGEN RECEPTOR | B Cell Antigen Receptor |
0.1 | 3.1 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.1 | 0.7 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
0.1 | 1.4 | PID RETINOIC ACID PATHWAY | Retinoic acid receptors-mediated signaling |
0.1 | 0.2 | SA B CELL RECEPTOR COMPLEXES | Antigen binding to B cell receptors activates protein tyrosine kinases, such as the Src family, which ultimate activate MAP kinases. |
0.1 | 1.3 | ST TUMOR NECROSIS FACTOR PATHWAY | Tumor Necrosis Factor Pathway. |
0.1 | 1.2 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
0.1 | 2.2 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
0.1 | 0.1 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
0.1 | 0.1 | PID AVB3 OPN PATHWAY | Osteopontin-mediated events |
0.1 | 0.3 | PID IGF1 PATHWAY | IGF1 pathway |
0.1 | 0.1 | ST PAC1 RECEPTOR PATHWAY | PAC1 Receptor Pathway |
0.1 | 1.9 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
0.1 | 0.9 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.1 | 1.7 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
0.1 | 1.3 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
0.1 | 0.9 | PID EPO PATHWAY | EPO signaling pathway |
0.1 | 1.2 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
0.1 | 0.4 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
0.0 | 8.7 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.0 | 0.1 | SA TRKA RECEPTOR | The TrkA receptor binds nerve growth factor to activate MAP kinase pathways and promote cell growth. |
0.0 | 0.5 | PID IL1 PATHWAY | IL1-mediated signaling events |
0.0 | 0.7 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
0.0 | 0.8 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.0 | 0.0 | PID ER NONGENOMIC PATHWAY | Plasma membrane estrogen receptor signaling |
0.0 | 0.2 | SIG PIP3 SIGNALING IN CARDIAC MYOCTES | Genes related to PIP3 signaling in cardiac myocytes |
0.0 | 0.4 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
0.0 | 0.1 | PID S1P S1P3 PATHWAY | S1P3 pathway |
0.0 | 0.1 | PID AVB3 INTEGRIN PATHWAY | Integrins in angiogenesis |
0.0 | 0.1 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
0.0 | 0.2 | ST INTERFERON GAMMA PATHWAY | Interferon gamma pathway. |
0.0 | 0.1 | PID CD40 PATHWAY | CD40/CD40L signaling |
0.0 | 1.0 | PID ERA GENOMIC PATHWAY | Validated nuclear estrogen receptor alpha network |
0.0 | 0.1 | PID PI3KCI PATHWAY | Class I PI3K signaling events |
0.0 | 0.4 | PID TNF PATHWAY | TNF receptor signaling pathway |
0.0 | 0.5 | PID CDC42 PATHWAY | CDC42 signaling events |
0.0 | 0.1 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.0 | 0.1 | PID NECTIN PATHWAY | Nectin adhesion pathway |
0.0 | 0.0 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
0.0 | 0.0 | PID PI3K PLC TRK PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.9 | 0.9 | REACTOME GAB1 SIGNALOSOME | Genes involved in GAB1 signalosome |
0.8 | 10.9 | REACTOME ACTIVATION OF RAC | Genes involved in Activation of Rac |
0.7 | 10.4 | REACTOME N GLYCAN ANTENNAE ELONGATION | Genes involved in N-Glycan antennae elongation |
0.7 | 6.5 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
0.6 | 4.6 | REACTOME THE ACTIVATION OF ARYLSULFATASES | Genes involved in The activation of arylsulfatases |
0.6 | 11.7 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
0.5 | 11.4 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.5 | 5.3 | REACTOME DOPAMINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Dopamine Neurotransmitter Release Cycle |
0.4 | 7.3 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
0.4 | 5.4 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
0.4 | 6.9 | REACTOME CGMP EFFECTS | Genes involved in cGMP effects |
0.4 | 2.8 | REACTOME OPSINS | Genes involved in Opsins |
0.4 | 15.4 | REACTOME O LINKED GLYCOSYLATION OF MUCINS | Genes involved in O-linked glycosylation of mucins |
0.3 | 7.7 | REACTOME CYTOSOLIC TRNA AMINOACYLATION | Genes involved in Cytosolic tRNA aminoacylation |
0.3 | 3.9 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.3 | 0.3 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
0.3 | 8.9 | REACTOME GLUCAGON TYPE LIGAND RECEPTORS | Genes involved in Glucagon-type ligand receptors |
0.3 | 2.6 | REACTOME PROTEOLYTIC CLEAVAGE OF SNARE COMPLEX PROTEINS | Genes involved in Proteolytic cleavage of SNARE complex proteins |
0.2 | 2.1 | REACTOME HORMONE LIGAND BINDING RECEPTORS | Genes involved in Hormone ligand-binding receptors |
0.2 | 2.4 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
0.2 | 5.2 | REACTOME A TETRASACCHARIDE LINKER SEQUENCE IS REQUIRED FOR GAG SYNTHESIS | Genes involved in A tetrasaccharide linker sequence is required for GAG synthesis |
0.2 | 2.0 | REACTOME SYNTHESIS OF PIPS AT THE LATE ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the late endosome membrane |
0.2 | 6.7 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
0.2 | 2.5 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
0.2 | 0.9 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
0.2 | 5.8 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
0.2 | 1.2 | REACTOME PROSTANOID LIGAND RECEPTORS | Genes involved in Prostanoid ligand receptors |
0.1 | 1.6 | REACTOME SEROTONIN RECEPTORS | Genes involved in Serotonin receptors |
0.1 | 0.1 | REACTOME APC C CDC20 MEDIATED DEGRADATION OF MITOTIC PROTEINS | Genes involved in APC/C:Cdc20 mediated degradation of mitotic proteins |
0.1 | 2.1 | REACTOME JNK C JUN KINASES PHOSPHORYLATION AND ACTIVATION MEDIATED BY ACTIVATED HUMAN TAK1 | Genes involved in JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 |
0.1 | 1.5 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
0.1 | 2.3 | REACTOME MITOCHONDRIAL TRNA AMINOACYLATION | Genes involved in Mitochondrial tRNA aminoacylation |
0.1 | 1.0 | REACTOME G BETA GAMMA SIGNALLING THROUGH PI3KGAMMA | Genes involved in G beta:gamma signalling through PI3Kgamma |
0.1 | 1.3 | REACTOME PYRUVATE METABOLISM AND CITRIC ACID TCA CYCLE | Genes involved in Pyruvate metabolism and Citric Acid (TCA) cycle |
0.1 | 1.0 | REACTOME TRANSPORT OF ORGANIC ANIONS | Genes involved in Transport of organic anions |
0.1 | 1.9 | REACTOME ZINC TRANSPORTERS | Genes involved in Zinc transporters |
0.1 | 5.0 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
0.1 | 1.3 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
0.1 | 1.2 | REACTOME ADENYLATE CYCLASE ACTIVATING PATHWAY | Genes involved in Adenylate cyclase activating pathway |
0.1 | 0.1 | REACTOME DOWNSTREAM SIGNALING EVENTS OF B CELL RECEPTOR BCR | Genes involved in Downstream Signaling Events Of B Cell Receptor (BCR) |
0.1 | 1.9 | REACTOME CIRCADIAN REPRESSION OF EXPRESSION BY REV ERBA | Genes involved in Circadian Repression of Expression by REV-ERBA |
0.1 | 0.3 | REACTOME G BETA GAMMA SIGNALLING THROUGH PLC BETA | Genes involved in G beta:gamma signalling through PLC beta |
0.1 | 2.4 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
0.1 | 1.7 | REACTOME DESTABILIZATION OF MRNA BY TRISTETRAPROLIN TTP | Genes involved in Destabilization of mRNA by Tristetraprolin (TTP) |
0.1 | 1.2 | REACTOME KERATAN SULFATE BIOSYNTHESIS | Genes involved in Keratan sulfate biosynthesis |
0.1 | 0.6 | REACTOME MICRORNA MIRNA BIOGENESIS | Genes involved in MicroRNA (miRNA) Biogenesis |
0.1 | 1.9 | REACTOME TRANSPORT TO THE GOLGI AND SUBSEQUENT MODIFICATION | Genes involved in Transport to the Golgi and subsequent modification |
0.1 | 2.0 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
0.1 | 0.4 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
0.1 | 0.8 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
0.1 | 1.3 | REACTOME CYCLIN A B1 ASSOCIATED EVENTS DURING G2 M TRANSITION | Genes involved in Cyclin A/B1 associated events during G2/M transition |
0.1 | 0.8 | REACTOME GAP JUNCTION DEGRADATION | Genes involved in Gap junction degradation |
0.1 | 0.9 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
0.1 | 0.3 | REACTOME BINDING AND ENTRY OF HIV VIRION | Genes involved in Binding and entry of HIV virion |
0.1 | 0.5 | REACTOME METAL ION SLC TRANSPORTERS | Genes involved in Metal ion SLC transporters |
0.1 | 0.9 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
0.1 | 0.9 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
0.1 | 1.0 | REACTOME RAS ACTIVATION UOPN CA2 INFUX THROUGH NMDA RECEPTOR | Genes involved in Ras activation uopn Ca2+ infux through NMDA receptor |
0.1 | 1.7 | REACTOME AMINE COMPOUND SLC TRANSPORTERS | Genes involved in Amine compound SLC transporters |
0.1 | 3.3 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
0.1 | 1.2 | REACTOME FORMATION OF TUBULIN FOLDING INTERMEDIATES BY CCT TRIC | Genes involved in Formation of tubulin folding intermediates by CCT/TriC |
0.1 | 2.7 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
0.1 | 0.5 | REACTOME GLUTAMATE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Glutamate Neurotransmitter Release Cycle |
0.1 | 0.7 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
0.1 | 0.5 | REACTOME RECRUITMENT OF NUMA TO MITOTIC CENTROSOMES | Genes involved in Recruitment of NuMA to mitotic centrosomes |
0.1 | 0.4 | REACTOME GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION | Genes involved in GABA synthesis, release, reuptake and degradation |
0.0 | 0.4 | REACTOME IKK COMPLEX RECRUITMENT MEDIATED BY RIP1 | Genes involved in IKK complex recruitment mediated by RIP1 |
0.0 | 0.7 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
0.0 | 0.6 | REACTOME GABA A RECEPTOR ACTIVATION | Genes involved in GABA A receptor activation |
0.0 | 0.1 | REACTOME PHOSPHORYLATION OF CD3 AND TCR ZETA CHAINS | Genes involved in Phosphorylation of CD3 and TCR zeta chains |
0.0 | 0.1 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
0.0 | 1.9 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
0.0 | 0.8 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |
0.0 | 0.0 | REACTOME ABORTIVE ELONGATION OF HIV1 TRANSCRIPT IN THE ABSENCE OF TAT | Genes involved in Abortive elongation of HIV-1 transcript in the absence of Tat |
0.0 | 0.1 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
0.0 | 0.5 | REACTOME METABOLISM OF POLYAMINES | Genes involved in Metabolism of polyamines |
0.0 | 0.3 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
0.0 | 1.4 | REACTOME NRAGE SIGNALS DEATH THROUGH JNK | Genes involved in NRAGE signals death through JNK |
0.0 | 0.5 | REACTOME TRANSPORT OF GLUCOSE AND OTHER SUGARS BILE SALTS AND ORGANIC ACIDS METAL IONS AND AMINE COMPOUNDS | Genes involved in Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds |
0.0 | 0.2 | REACTOME NOD1 2 SIGNALING PATHWAY | Genes involved in NOD1/2 Signaling Pathway |
0.0 | 1.2 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.0 | 0.2 | REACTOME BETA DEFENSINS | Genes involved in Beta defensins |
0.0 | 0.9 | REACTOME GLUCONEOGENESIS | Genes involved in Gluconeogenesis |
0.0 | 0.4 | REACTOME METABOLISM OF NON CODING RNA | Genes involved in Metabolism of non-coding RNA |
0.0 | 0.0 | REACTOME SCF BETA TRCP MEDIATED DEGRADATION OF EMI1 | Genes involved in SCF-beta-TrCP mediated degradation of Emi1 |
0.0 | 0.2 | REACTOME CREATION OF C4 AND C2 ACTIVATORS | Genes involved in Creation of C4 and C2 activators |
0.0 | 0.0 | REACTOME ACYL CHAIN REMODELLING OF PC | Genes involved in Acyl chain remodelling of PC |
0.0 | 0.1 | REACTOME UNBLOCKING OF NMDA RECEPTOR GLUTAMATE BINDING AND ACTIVATION | Genes involved in Unblocking of NMDA receptor, glutamate binding and activation |
0.0 | 0.3 | REACTOME SYNTHESIS OF SUBSTRATES IN N GLYCAN BIOSYTHESIS | Genes involved in Synthesis of substrates in N-glycan biosythesis |
0.0 | 0.2 | REACTOME PEPTIDE HORMONE BIOSYNTHESIS | Genes involved in Peptide hormone biosynthesis |
0.0 | 0.3 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.0 | 0.1 | REACTOME ADENYLATE CYCLASE INHIBITORY PATHWAY | Genes involved in Adenylate cyclase inhibitory pathway |
0.0 | 0.1 | REACTOME ASSOCIATION OF LICENSING FACTORS WITH THE PRE REPLICATIVE COMPLEX | Genes involved in Association of licensing factors with the pre-replicative complex |
0.0 | 0.1 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
0.0 | 0.1 | REACTOME PACKAGING OF TELOMERE ENDS | Genes involved in Packaging Of Telomere Ends |
0.0 | 0.1 | REACTOME NOTCH HLH TRANSCRIPTION PATHWAY | Genes involved in Notch-HLH transcription pathway |
0.0 | 0.5 | REACTOME NUCLEAR SIGNALING BY ERBB4 | Genes involved in Nuclear signaling by ERBB4 |
0.0 | 0.1 | REACTOME G ALPHA Z SIGNALLING EVENTS | Genes involved in G alpha (z) signalling events |
0.0 | 0.1 | REACTOME THE NLRP3 INFLAMMASOME | Genes involved in The NLRP3 inflammasome |
0.0 | 0.0 | REACTOME TRANSFERRIN ENDOCYTOSIS AND RECYCLING | Genes involved in Transferrin endocytosis and recycling |
0.0 | 0.0 | REACTOME NRIF SIGNALS CELL DEATH FROM THE NUCLEUS | Genes involved in NRIF signals cell death from the nucleus |
0.0 | 0.0 | REACTOME LIPID DIGESTION MOBILIZATION AND TRANSPORT | Genes involved in Lipid digestion, mobilization, and transport |
0.0 | 0.0 | REACTOME ACYL CHAIN REMODELLING OF PI | Genes involved in Acyl chain remodelling of PI |
0.0 | 0.2 | REACTOME CHONDROITIN SULFATE BIOSYNTHESIS | Genes involved in Chondroitin sulfate biosynthesis |
0.0 | 0.1 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
0.0 | 0.1 | REACTOME HIGHLY CALCIUM PERMEABLE POSTSYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Highly calcium permeable postsynaptic nicotinic acetylcholine receptors |